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     Amblyopia, or ‘lazy eye’, describes visual impairment occurring due to abnormal 
cortico-visual development as a child, and is the most common ophthalmological 
condition in children. The critical period for visual development in the human 
extends from birth to the around the ages of 7-9 years, and the development 
during this time occurs competitively between fellow eyes. Thus, any impairment 
in retinal image quality, neuronal function or misalignment of the eyes can lead to 
neuronal suppression of an eye, which may cause impaired visual acuity of that 
eye. Amblyopia can lead to issues later in life, such as limitation of occupational 
choices, poorer functional vision if something happens to the better-seeing eye, 
and an increased risk of vision loss in the better eye compared to individuals 
without amblyopia.  
     Amblyopia treatment is effective, however, so long as it occurs before the critical 
period of child cortico-visual development, and so, many societies have some form 
of child vision screening, so that children with amblyopia can be treated while 
effective treatment is still an option. In 2008, a nationwide screening programme 
was introduced in New Zealand: the B4 School Check (B4SC), and, currently, there 
is little data regarding the efficacy of the vision screening portion of the B4SC.  
     This study primarily aimed to assess the accuracy of the B4SC vision screening, 
by determining the positive predictive value, negative predictive value, sensitivity, 
and specificity of the programme. This was done by collecting data regarding 
visual acuity and referral status for all children screened by the B4SC within the 
Southern and Tairawhiti DHBs, and cross-matching this to data collected regarding 
these children who also presented to community optometrists and DHB eye clinics 
in the Southern and Tairawhiti DHB regions for comparison.  
     This study found that the positive predictive value for the B4SC was 53.5%. The 
negative predictive value was found to be between 96.1 and 99.9%, sensitivity was 
between 35.3 and 95.1%, and specificity was between 93.5 and 97.0%. It found 
that visual acuity testing is accurate, while it does have a low positive predictive 
value, the screening is performing its function of identifying cases of reduced 
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     The visual system of the human infant is immature: unable to steadily fixate on a 
given object, unable to resolve fine detail. But within the next 10 years of the 
infant’s life, that visual system will reach the level of functioning of a normal adult, 
to become a system able to discern fine details under a wide variety of viewing 
conditions, at different distances and in different directions, all with binocular 
fixation allowing for appreciation and processing of image disparity between the 
eyes (in all directions of gaze) into a sense of form and depth, or stereopsis. To 
appreciate this, one must understand the physiology of normal adult vision, 
appreciate the critical periods of visual development, and the susceptibility for 
interference with this process which can derail this normal development, and lead 
to life-long visual disability.(1) 
     Amblyopia is the most common ophthalmological condition in children, with a 
prevalence of approximately 1-4%(2), caused by abnormal cortico-visual 
development during childhood.  Development of the visual system occurs 
competitively between fellow eyes, which means any impairment of the retinal 
image quality, neuronal function, or misalignment of the eyes can lead to neuronal 
suppression of an eye, possibly impairing visual acuity of that eye. Amblyopia can 
lead to issues later in life with limitation of occupational choices, poorer functional 
vision if something happens to the good eye, and an increased risk of vision loss in 
the better eye compared to individuals without amblyopia.(3)  
     Amblyopia treatment is effective, however, so long as it occurs before the critical 
period of child cortico-visual development: about seven to nine years of age.(4) For 
this reason, many societies have some form of child vision screening, so that 
children with amblyopia can be treated while effective treatment is still an option.  
     In New Zealand (NZ), there has been some form of vision screening for over the 
past 40 years, and in 2008 a nationwide screening programme was introduced, the 
B4 School Check (B4SC), which includes hearing and vision screening. As of yet, 
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there is little data regarding the efficacy of the vision screening portion of the 
B4SC.  
 
Chapter One - Physiology of Vision 
 
1.1   Introduction 
     Vision is the perception and appreciation of patterns of visible light, and is 
achieved by a coordinated effort of many specialised structures in the eye and 
brain. The eye functions like a camera, transforming objects in one’s field of vision 
into images onto a film at the back of the eye, and then converting these into neural 
signals for the brain to process. Thus, there needs to be structures in the eye 
specialised for refracting and condensing all the light in one’s field of view onto a 
screen at the back of the eye, and structures specialised for converting this 
refracted light into action potentials to go to the brain for processing and complex 
visual functions. The main structures of the eye are outlined below (fig. 1). 
 






1.2   Refraction 
     Refraction of light in the eye is achieved with two structures. Light entering the 
eye first strikes the cornea, a curved, transparent, tough layer of collagen, 
beginning the process of refraction to eventually form a focussed image on the 
retina. The cornea is the more powerful refractive component of the eye, with a 
refractive power of around 43 dioptres. However, the refractive power and focal 
length for the cornea is normally constant.(5) 
     Light will next reach the other refractive element of the eye, the lens. The lens is 
a transparent, biconvex structure, essential in normal visual activity, and although 
it has less refractive power than the cornea, only between 13 and 26 dioptres, its 
refractive power is adjustable, unlike the cornea. It is this ability to adjust its focal 
length which enables one to look at objects near and far, and maintain a focussed 
retinal image, through a process called accommodation.  
     Accommodation is achieved by the ciliary muscle, a sphincter muscle located 
circumferentially around the lens, and attaching radially to the lens via huge 
numbers of zonular fibres, suspending the it in its position. The ciliary muscle 
receives parasympathetic innervation from the oculomotor nerve, via the ciliary 
ganglion, from the Edinger-Westphal nucleus. When one looks from an object at a 
distance to one that is near, the ciliary muscle contracts, and the diameter of the 
sphincter opening decreases, which relieves tension on the zonular fibres, 
rounding the lens due to its innate elasticity.(6) A rounded lens has a greater 
refractive power, and thus the eye can focus an image onto the retina for objects 
that are closer.(7) Accommodation happens autonomically, when an object is not 
focussed onto the retina. If an object is not in focus (i.e. the focal point of the image 
is in front or behind the retina), there will be a blurred retinal image. When one 
focusses on a near object, their eyes will converge and pupils constrict, as well as 




1.3   Retina 
     Once refracted by the cornea and lens, light is then focussed to form an image on 
the screen at the back of the eye, an outgrowth of the brain known as the retina. It 
is here that light is transformed into an action potential by photoreceptor cells 
deep in the retina, in a process called photo-transduction. The two types of 
photoreceptor cells are rods and cones. Cones are densely populated at the fovea 
of the retina, and are responsible for colour vision and high visual acuity.(10) 
There are three types of cones, which are specialised for detecting long, medium, 
and short wavelengths of light, corresponding to different colours of light.(11) 
Rods are optimised for vision in low levels of light, activated by a single photon, as 
opposed to hundreds of photons required to activate a cone.(12,13)    
     Photoreceptors cells contain the photopigment rhodopsin, a molecule that is 
vital to the process of photo-transduction. Rhodopsin is made of opsin, a type of G 
protein-coupled receptor (GPCR), and retinal, in an 11-cis isomer configuration. 
When a photon strikes rhodopsin, 11-cis retinal is converted to all- trans retinal, 
producing changes in the opsin to form metarhodopsin II, which then activates 
transducin, a G protein. Transducin leads to decreased levels of cGMP, closing Na+ 
channels, stopping a flow of Na+ into the cell, and thereby causing 
hyperpolarisation. This causes decreased release of glutamate, an excitatory 
neurotransmitter, that can bind to receptors on horizontal and bipolar cells and, 
depending on the type of receptor, will excite, or inhibit the cell. In the dark, cGMP 
levels are high, and cGMP-gated sodium channels remain open allowing a steady 
inward Na+ current, known as the ‘dark current’, keeping the photoreceptor cell 
depolarised, and increasing the levels of glutamate.(14,15) 
     Photo-transduction allows the conversion of light into a visual potential, and 
thus allows a means of signalling visual information to the brain. The 
photoreceptor cells will synapse with bipolar cells, which in turn synapse onto 
retinal amacrine cells. Both bipolar cells and retinal amacrine cells will synapse 
onto retinal ganglion cells, the axons of which comprise the optic nerve. The 
ganglion cell axons are firstly non-myelinated, as the axons pass over the rest of 
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the retina, but become myelinated once they reach the optic disc, the point where 
the optic nerve exits the retina.(16)  
     The receptive field of retinal ganglion cells refers to the space on the retina 
where changes to the stimulation of the photoreceptors there will affect the output 
from the ganglion cells. A smaller receptive field means that the ganglion cell has 
connections with fewer photoreceptor cells than in a larger receptive field, which 
means that a smaller receptive field can detect smaller differences between 
stimuli, increasing its discriminative ability. The receptive field organisation on the 
retina is maintained throughout the visual pathways in the brain.(17)  
 
1.4   The Brain 
 
     The optic nerve carries all visual information from the retina. Fibres of the optic 
nerve carrying information from the nasal hemiretina of each eye (responsible for 
the temporal field of view) will decussate to the contralateral side, at a point 
known as the optic chiasm, and continue inside through the optic tract. Fibres from 
the temporal hemiretina do not cross, and will remain on the ipsilateral side of 
both the optic nerve and the optic tract. The two optic tracts relay visual 
information to the lateral geniculate nuclei (LGN) of the thalamus on each side 
ipsilaterally, as well as to the superior colliculi and pretectal areas of the brain. The 
optic radiation, made of axons from the neurons of the LGN, travels to and 
synapses on the primary visual cortex (V1).(18) 
     The cortical area responsible for vision is in the occipital lobe, which is divided 
into several functional areas, for differing levels of visual processing. The visual 
cortex consists of V1, as well as extrastriate areas (V2, V3, V4, V5).(19) V1 is 
organised into six layers, and is structured topographically to correspond to 
different areas of the retina so that, for example, the fovea is represented at the 
occipital pole, and the peripheral retina is represented in the anterior margin of 
the calcarine fissure.(20,21) V1 functions to interpret patterns of visual potentials 
into visual perception and cognition, and discern the size, orientation, and 
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direction of objects in a dynamic field of view, and, along with memory and other 
sensory context, describe what objects are and where they are moving.  
     V1 cell firing encodes for local features of images, particularly orientation, and 
many V1 cells respond to a preferred orientation of visual input, known as 
orientation selectivity. Also, many neurons will respond to one direction of motion 
of a visual stimulus more readily than others, known as direction selectivity. This 
property is thought to arise from a delay in inputs between cortical cells with the 
same orientation selectivity, and one cell enhancing or suppressing the response of 
the next one.(22) As there is a precise topographical map of the visual field 
represented in V1, Hubel and Wiesel proposed that V1 is organised as a series of 
repeating modules, which contains the necessary components to analyse one part 
of a visual field, termed hypercolumns.(23) Each hypercoloumn contains a left and 
right eye ocular dominance column, which are layers of cells that respond more to 
input from one eye or the other, for a given field of view. Ocular dominance 
columns contain high levels of a protein called cytochrome oxidase, and are 
thought to be important in binocular vision.(24)  
 
1.5   Binocularity 
 
     Normal visual functioning requires the use of two eyes, and produces the 
perception of a singular visual reality. For binocular vision to be successful each 
eye must be able to move together in the same direction to maintain alignment, 
and the brain must combine two visually similar but slightly different images in a 
process called fusion, interpreting subtle differences between these images to 
determine differences in depth, or stereopsis.  
     Alignment and movement of each eye is achieved with six muscles around it, 
referred to as the extra-ocular muscles. Each eye has four rectus muscles, arising 
from a common tendinous ring, located postero-medially at the apex of the orbit. 
These are the lateral, superior, medial, and inferior recti, and generally move the 
eye in the direction suggested by their name. The other two extraocular muscles 
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are the superior and inferior oblique. These insert onto the eye behind its axis of 
rotation, so the superior oblique will depress the eye, (as well abduct it), and the 
inferior oblique will elevate the eye (as well as abduct it). The lateral rectus muscle 
is innervated by cranial nerve VI (abducens), which arises from the pons. The 
superior oblique muscle is innervated by cranial nerve IV (trochlea), arising from 
the midbrain. All the other extraocular muscles are innervated by cranial nerve III 
(the oculomotor nerve). The extraocular muscles work in conjunction, so that 
opposing pairs will act together, so each eye can move in conjugate gaze and 
maintain ocular alignment.(25) 
     Each eye will produce its own retinal image, but normally one only perceives a 
single image. The unification of the two retinal images into one is known as 
sensory fusion, a process is occurring in V1 and requiring two sufficiently similar 
retinal images; similar in size, brightness, and clarity. Motor fusion, also arising 
from V1, is the ability to be able to align the eyes so that sensory fusion is 
maintained. If there is disparity between the retinal images, this will stimulate eye 
movements to try to restore sensory fusion.(26,27)  
     Stereopsis is the ability of the visual system to determine the depth between 
objects in one’s field of view. This function relies on the fact that the two eyes can 
fixate on the same object simultaneously, while also having a slight separation in 
space, meaning the eyes receive two slightly different images, as the eyes will have 
slight differences in the angle at which they are directed to the object. V1 can 
process these binocular disparities to determine how far away various objects are, 
and thus build a 3-Dimensional perception of the visual world.(28)  
 
1.6   Normal visual development 
 
     The formation of the normal, mature visual system requires a number of 
anatomical and physiological changes in the eye and brain, which are occurring 
from infancy to about seven years of age. The visual system at birth, while allowing 
some crude vision, is still incomplete, and further development will be mostly 
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guided by visual experiences.(29) Changes to the visual anatomy include increase 
in globe length, changes to the retina, such as pruning ganglion cells, as well as the 
formation and specialisation of neuronal connections in cortical and sub-cortical 
visual centres, via growth and apoptosis.(30,31)  
     The development of the cortical visual centres is a complex process. Major 
outcomes from this growth include the development and refinement of complex 
visual functions, such as high visual acuity (VA), binocularity, stereopsis, contrast 
sensitivity, and motion sensitivity, and development of these will depend on both 
innate and stimuli-dependent factors.(32) The development of these processes 
happens by selecting for and cultivating the necessary neuronal networks that are 
stimulated by each eye. This happens via competitive inhibition between fellow 
eyes, each eye competing for consolidation of connections in V1 with its ocular 
dominance column. The two eyes each stimulate connections amongst cortical 
visual centres, which continually reinforces (or deteriorates, in the case of lack of 
stimulation) cortico-visual connections.  
     Postnatal vision development requires normal visual stimulation, specifically 
the presence high quality visual images which are concordant between fellow eyes. 
As the two retinae are stimulated with clear images that are sufficiently similar, so 
that they can be fused, the cortical areas responsible for vision (V1 and the LGN) 
mature. The density of neurons here increases, along with the strength of 
synapses. Normal visual development requires clear retinal images, equal image 
clarity and proper eye alignment, and so anything affecting one or more of these 
can lead to aberrant visual development.(33) 
     Striatal neurons are innately specialised for either binocular or monocular 
vision. As vision develops normally, equal proportions of monocular neurons 
become innervated by afferent neurons from the two eyes, and so each eye will 
develop equal synaptic representation in the brain. 
     Postnatally, VA is poor, due to the immaturity of V1 and the LGN. Infants also 
have increased use of para-foveal photoreceptors during fixation, meaning visual 
fixation is not utilising the densely packed cone photoreceptors of the fovea, the 
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area responsible for high visual acuity.(34) Normally, VA rapidly improves as 
visual centres are stimulated with exposure to high quality retinal images, of equal 
and sufficient clarity, as well as proper eye alignment. Fixation begins to happen at 
the fovea, thus allowing a greater number of cones to be used. By ages 5-6 years, a 
child’s VA approaches the level of adult VA.(35) Contrast sensitivity (CS), the 
smallest difference between to different contrasts of light that the visual system 
can distinguish, improves as cones develop at the fovea.(36) The onset of binocular 
function and stereopsis in infants is about three months, and again, the 
development of these processes depend on clear and sufficiently equal retinal 
images.(1) 
 
1.7   Critical Periods for Visual Development 
 
     The critical period of visual development is a period during post-natal 
development when the visual pathways are highly plastic, and in which certain 
visual experiences are required for normal maturation. Visual experiences during a 
critical period can permanently alter the development of the visual system.(37) 
Neuronal connections of the visual pathways are susceptible to experiential-
dependent changes. The length of critical period of visual development in humans 
is usually thought to be around seven or eight years of age, though it is not 
precisely defined. The specific lengths of critical periods also differ between 
cortical locations, and in general, higher visual processing sites tend to have longer 
periods of plasticity.   
     Any changes which occurs in the LGN and V1 during the critical period are often 
unable to be reversed once the period is over, and so any aberrant changes that 
may have occurred during visual development will likely persist for the patient’s 
life.(4) However, there is some evidence that the adult brain does retain some 
neuroplasticity. In people with amblyopia who lose vision in the ‘better’ eye, 
approximately 10% of them will have an improvement in their VA of the amblyopic 
eye, suggesting that there is some residual plasticity. However, the potential for 
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change and improvement to abnormal visual centres in an adult is greatly less than 
the potential for change and improvement in a visually-developing child, and 
therefore, children should still be the main recipients of amblyopia prevention and 
treatment.(38) 
     More evidence for existence of critical periods is that full time vision deprivation 
in an adult cat has no detectable effects, as opposed to monocular visual 
deprivation in kittens, which has been shown to decrease vision in the deprived 




Chapter Two - Amblyopia 
2.1   What is amblyopia? 
 
     Amblyopia, or “lazy eye”, is the most common cause of visual impairment in 
children, and will often persist into adulthood.(39) It is a cortical deficit which 
appears as a decrease in the best-corrected visual acuity (BCVA) in usually one eye, 
but potentially both, and there is a dysfunction in the processing of visual 
information.(40) Amblyopia arises from abnormal visual stimulation during visual 
development. (41) 
 
2.2   Definition of Amblyopia 
 
     For this thesis, amblyopia will be defined using the same definition used for the 
B4 School Check: a reduction of the best-corrected visual acuity that cannot be 
attributed entirely to any other abnormality in the visual system.(42) 
     There is a number of different definitions for amblyopia in the literature, 
however. Other commonly used definitions include a developmental disorder of 
spatial vision, or pathology resulting from optical deficits in childhood.(40,43) 
     There is also variation in the literature regarding the exact quantitative 
definition of amblyopia, and what should be the visual acuity cut-off for clinical 
diagnosis, varying between regions, types of test used, and clinician preference. 
Commonly accepted clinical definitions of amblyopia include a BCVA of 6/12 or 
worse in either eye, a BCVA of 6/9 or worse in either eye, or a two-line logMAR 
difference between eyes, in the absence of other ocular or cortical disease to better 
explain the visual defect. Some definitions also require the presence of an 
amblyopia risk factor, such as strabismus or anisometropia.(44–46) 
     Currently, there is debate on what levels of VA are normal in children, and what 
is a normal level of VA difference between eyes. It has been suggested that a VA of 
up to 6/12 may be normal in young children aged 3-4 years.(47) 
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     The B4SC Vision Screening Programme, the national vision screening 
programme for children at four years old in NZ, employs a BCVA of 6/9 or worse in 
either eye as the threshold for referral, i.e. a positive amblyopia screen, and hence 
will be the quantitative definition for amblyopia diagnosis used for this thesis.(42) 
 
2.3   The Cause of Amblyopia 
 
     Amblyopia is caused by abnormal development of the cortico-visual system. 
Abnormal development of the visual system occurs secondarily to abnormal 
stimulation of the visual centres of a young child, and this may occur in any 
condition affecting the clarity and formation of a retinal image, or any condition 
causing significant differences between fellow retinal images.(48) While the cause 
of amblyopia is something that affects the formation of clear and balanced images 
on the retina, the actual locations of the changes that occur in amblyopia are in the 
brain, specifically in the lateral geniculate nucleus (LGN) of the thalamus, and the 
primary visual cortex (V1).(33) 
 
2.4   Amblyopia development 
 
     Amblyopia can be caused by anything that leads to abnormal visual stimulation 
in early childhood, during the critical period of visual development. This abnormal 
visual experience can be either a reduced quality of visual input or abnormal 
binocular interaction, causing insufficient, or inappropriate, stimulation of visual 
centres, inhibiting normal visual development.(44) 
     Pattern deprivation can result from significant refractive error, blurring the 
image on the retina, or a media opacity, which obstructs the visual axis of the eye. 
Fine details are lost, which leads to cortical suppression of the visual pathways 
from that eye. Abnormal binocular interaction can result from strabismus, an 
ocular misalignment, or anisometropia, a difference in the refractive states of each 
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eye. This binocular discordance in a young child results in abnormal changes to the 
highly malleable visual cortex, as the brain is trying to process two images which 
are unable to be fused. Pattern deprivation and abnormal binocular interaction can 
occur independently or together.(49) 
     The eyes develop competitively with each other, and abnormal stimulation from 
one eye can mean there is decreased cortical activity in the areas representing that 
eye, and so, there may be fewer neurons selected to be driven by that eye in future 
visual activity. Monocular neurons from the abnormal eye begin to be crowded-out 
due to decreased stimulation, and some begin to differentiate into neurons driven 
by the fellow, better-functioning eye.  
     A blurred retinal image leads to that eye being selected against, while the 
‘better’ eye is favoured, and will begin to dominate visual activity. Most visual-
cortical neurons may come to represent the better-seeing eye. In amblyopia, the 
equal balance of neurons driven by each eye is lost. Eventually, in moderate to 
severe cases of amblyopia, most cells in V1 begin to only respond to stimulation 
from the better-seeing eye.(50) This may progress to the point where the 
amblyopic eye is absent from most vision, depending on the severity of the loss of 
image quality.(51)   
     Visual deprivation can lead to the cortical cells stimulated by the deprived eye 
becoming unresponsive to stimulation, and causes a sharp decrease in the number 
of cells that are driven by the afflicted eye.(33) This process is thought to occur 
due to a disruption of connections that are present at birth.(52)  
 
2.5   Types of Amblyopia 
 
     Amblyopia can be grouped according to the underlying cause. The main causes 
of amblyopia are refractive error (RE), strabismus, and deprivation, and either one 




2.5.1   Refractive Amblyopia 
 
     Untreated refractive errors in children may cause amblyopia, in addition to 
being a common cause of a reduced in visual acuity in children in themselves. 
Refractive errors in children include hypermetropia, myopia, astigmatism, and 
anisometropia. RE occurs when the power of the refractive system of the eye is not 
appropriate for its length. ‘Normal’ or ‘physiological’ refractive errors occur in 
young children aged around 1-4 years, when the power of the refractive system is 
not appropriate for the length of the eye, since the eye still must grow and increase 
its length. This creates a slightly hypermetropic refractive state, but this often 
normalises, in a process called emmetropisation, as the length of the globe 
increases, under stimulation from the hypermetropic refractive state.(53,54) 
     Emmetropia is the state of normal refraction, when the refractive power of the 
lens and cornea is suitable for the length of the globe, so that a clear image is 
projected directly onto the retina, rather than in front or behind it (fig. 2). This 
maximises VA, as the retinal image is not blurry, and therefore the greatest amount 
of detail can be perceived.  
 




     Myopia is a refractive error that occurs when light is focussed in front of the 
retina, instead of onto it. This can be due to the refractive power of the lens and 
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cornea being too great, or the length of the globe being too long (fig. 3). Myopia will 
mean that distant objects will appear out of focus, but does not usually affect the 
focus for objects that are closer.(55) When looking at objects that are further away, 
the lens is in its thinnest configuration, and thus in its position with the least 
refractive power. In the myopic eye, when looking at objects further away, its 
lowest level of refractive power is still too great, and thus the image is formed in 
front of the retina. However, when looking at an object that is closer, the lens will 
need to have an increased refractive power. This means a myopic eye looking at an 
object that is near already has sufficient refractive power, and can focus an image 
directly onto the retina.  
 
Figure 3: Diagram of Myopia 
 
     Myopic children are usually not as likely to develop amblyopia compared to 
children with other types of refractive errors. Children with myopia usually have 
good near-vision, which is usually sufficient to provide the necessary visual 
activity for normal visual development.(56)  
     The clinical guidelines for the NZ Children’s Spectacle Subsidy for myopia in 
children aged four to six years is -1.50D or more, and so this will be the definition 
for myopia used in this thesis.(57) 
     The prevalence of myopia varies considerably, depending on race, age, country, 
and sex. Most myopia appears during childhood, particularly during school. In 
Asian populations, it has a relatively high prevalence of around 40-50%. In 
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Australia, the prevalence of myopia has been estimated at around 17% of the total 
population, and at about 8% of the population of children.(58–61)  
     The cause of myopia appears to be an amalgamation of genetic and 
environmental factors. Studies into the genetics of myopia have identified 18 
potential loci that are associated with myopia. However, no single gene appears to 
be entirely causal, and the genetic basis appears to be an interaction of multiple 
genes.(62,63) Genetics does not entirely explain variation in myopia epidemiology, 
and there is also an environmental component to myopia, and environmental 
conditions seem to be a major cause in the increasing prevalence of myopia around 
the world. (69,70) Possible environmental factors affecting myopia development 
are the amount of outdoor activity and socialisation in childhood.(64)   
     Myopia can often be corrected by reducing the effect of the over-powered lens of 
the eye with concave corrective lenses, which have a negative focal length. The 
negative focal length can balance the relatively high power of the eye. This shifts 
the light rays entering the eye, so that they now focus onto the retina, rather than 





     Hypermetropia is when the optical power of the eye is too weak, or the length of 
the globe is too short comparatively, and light is focussed beyond the retina (fig.4). 
The prevalence of hypermetropia is around 5-13% of the population, and it is more 




Figure 4: Diagram of Hypermetropia 
 
     In adults, hypermetropia usually results in a reduction of near vision, while 
distance vision can remain somewhat normal. This is because when looking at 
objects that are distant, the increased refractive power required is able to be 
provided through accommodation. However, for objects that are close, the eye 
requires more refractive power, which may be more than can be comfortably 
provided by accommodation. Hypermetropia is often present from birth, but 
children have a rather flexible eye lens, which can often compensate for this 
hypermetropia. However, the refractive error will often present once there is loss 
of this accommodation, which happens naturally with age.  
     Infants with hypermetropia of +2.50 D or greater are 20 times as likely develop 
strabismus or amblyopia than their emmetropic peers. Hypermetropia greater 
than +4.50 is quite likely to cause amblyopia if untreated.(67)  High levels of 
hypermetropia may cause bilateral amblyopia, as there can be decreased image 
quality on both retinae. This means that there is insufficient visual information 
being received, which may prevent the development of normal vision in the visual 
cortex.  
     The clinical guidelines for the NZ Children’s Spectacle Subsidy for 
hypermetropia in children aged four to six years is 2.50D or more, and so this will 
be the definition for hypermetropia used in this thesis.(57) Correction of 
hypermetropia is usually with spectacles, done using convex lenses, with a positive 






     Astigmatism is when there is an irregular curvature of the cornea or lens. This 
means that rather than being spherical, the shape of the refractive system is 
asymmetrical, and the focal point of the eye differs in two different meridians 
(planes). The prevalence of astigmatism in children is estimated to be around 1-
3%, and the prevalence is also thought to be higher in older children.(68,69) 
     Astigmatism may be asymptomatic in low severity cases, but high levels of 
astigmatism may lead to blurred vision, eye strain and headaches. Astigmatism 
greater than +4.50 is likely to cause amblyopia, particularly oblique 
astigmatism.(70)  
     The clinical guidelines for the NZ Children’s Spectacle Subsidy for astigmatism in 
children aged four to six years is 1.50D or more, and therefore will be the 
definition of astigmatism used in this thesis.(57) Treatment of astigmatism is with 
optical correction, such as spectacles. The corrective lenses are made in a way to 
account for differences in refraction in both planes. Treatment of astigmatism is 




     Anisometropia means that there is a difference in the refractive states between 
fellow eyes, either due to myopia, hypermetropia, or astigmatism, or a combination 
of these, which is not even between the eyes.  
     The significance of anisometropia is that the eyes are unable to focus on the 
same object simultaneously, and therefore will receive a different visual input. The 
two retinae will not have similarly refracted images, and thus there will be cortical 
binocular discordance. This causes a visual pathway from one of the eyes (usually 
the more ametropic) to be suppressed. Also, the significantly blurred retinal image 
of the more ametropic eye may lead to a further decrease in cortical development 
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for that eye. Over a sufficient period, this suppression and issue with development 
can cause amblyopia. Anisometropia is more amblyogenic than symmetrical RE, 
per unit dioptre, as it also allows for the favoured use and development of one side 
of the visual system. This is especially true for anisometropic hypermetropia, as 
the child can accommodate to make either eye focus, but never both 
simultaneously, and will generally favour the least hypermetropic eye, as that 
requires the least accommodative effort.(71,72)  
     Anisometropic amblyopia is usually milder than other forms of amblyopia, and 
often relatively treatable. Children with pure anisometropic amblyopia have the 
best initial VA compared to the strabismic and pattern deprivation types.(73) This 
is perhaps since both eyes are participating in visual activity somewhat, even 
though the clarity of the image in one eye is diminished. However, a worse severity 
of anisometropia is correlated to a worse VA in anisometropia amblyopia.(74) 
     The prevalence of anisometropia can be difficult to measure, especially since 
there is differing definitions of the boundary of anisometropia and isometropia 
(equal refractive states between eyes). However, it has been estimated that 
anisometropia occurs in around 4-6% of children older than four years.(75–77) 
Anisometropic amblyopia accounts for about a third of the cases of 
amblyopia.(44,78)  
     The clinical guidelines for the NZ Children’s Spectacle Subsidy, which are based 
on the Preferred Practice Guidelines for Prescribing Eye Glasses in Young Children 
from the American Academy of Ophthalmology, for anisometropia optical 
prescription in children four years and older, are 1.00D or more of hypermetropic 
anisometropia, 1.50D or more of cylindrical anisometropia, or 2.00D or more of 
myopic anisometropia. Therefore, these will be the clinical definitions for 
anisometropia used in this thesis.(57) Anisometropia is usually corrected with 
spectacles. However, spectacles with different optical powers may be problematic, 
as this will cause images on the retina to have different magnifications between the 
eyes, a phenomenon known as aniseikonia, which ought to be taken into 
consideration when prescribing optical correction, but only occurs on the 




2.5.2   Strabismic Amblyopia 
 
     Another major cause of amblyopia is strabismus. Strabismus is a condition in 
which the eyes are misaligned. Normally, when looking it an object both eyes are 
directed towards that object. In strabismus, however, one of the eyes is not 
directed towards the object at which the patient is looking. Strabismus can affect 
either eye, and any direction of ocular movement. Strabismus is present in about 2-
4% of children, and is more prevalent in older children than younger.(80–82) Low 
birth weight and a positive family history are risk factors for strabismus.(83)  
 
     Strabismus can either be manifest or latent. Manifest strabismus, given the 
suffix “tropia”, is when the deviation of an eye is present while the eyes are 
working together (or attempting to). Latent strabismus, given the suffix “phoria”, is 
when the deviation only occurs when binocular vision has been interrupted. 
Strabismus can also be grouped per the direction of the deviation. The deviation of 
an eye can be inwards, which is given the prefix “eso”, outwards, which is given the 
prefix “exo”, upwards, which is given the prefix “hyper”, downwards, which is 
given the prefix “hypo”, or rotational, which is given the prefix “cyclo”.   
     The most common type of strabismus in children is accommodative 
esotropia.(84) This is usually associated with hypermetropia. When one changes 
their visual focus from a distance to relatively near, they can maintain focus via 
accommodation. Focussing on a near object requires output form the Edinger-
Westphal nucleus, which responds with what is known as the ‘near triad’: lens 
accommodation, convergence of the eyes, and miosis.(85) In the case of a child 
who is hypermetropic, they may be able to compensate their hypermetropia with 
accommodation, as their lens is relatively labile. However, this accommodation will 
result from the ‘near triad’, which also causes the eyes to converge unnecessarily, 
hence creating an esotropia.  
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     Strabismus may also be caused by palsy or issue with the development of one or 
more cranial nerves innervating extra-ocular muscles, an issue with the extra-
ocular muscles themselves, such as congenital fibrosis, an abnormality of the 
affected eye causing decreased vision, or trauma or infection to the globe or orbit. 
Strabismus is also associated with several congenital conditions such as Down 
syndrome, cerebral palsy, and Edwards syndrome. (86) 
     Strabismus may not have a significant effect on a child’s functional vision. In 
adults, strabismus can cause diplopia because a different image is being formed on 
the retina of each eye. However, in children the brain can ignore on of the inputs 
from an eye if the two inputs are significantly different, termed suppression. Thus, 
children with strabismus rarely complain of diplopia or any symptom of their 
strabismus. 
     This suppression eliminates the symptom of diplopia but causes cortical 
suppression of the image arising from the deviating, non-fixing eye. However, 
when this occurs during critical periods of development, it leads to inevitable 
consequences for the competitive visual development of each eye’s visual pathway, 
and can cause decreased stereopsis in children.(87) If a strabismic child has a 
strong preference for using one eye over the other for vision, the other eye may 
become amblyopic. Children with strabismus who also have alternate fixation tend 
to not develop amblyopia, since there is no long-term suppression of one eye. 
However, they may not develop normal binocular vision, as they do not use their 
eyes simultaneously.  
     Strabismus can also have lasting psychosocial impacts on patients, and it is 
thought to have a negative impact on many aspects of patient’s lives, including 
decreased self-esteem, employment, and relationships.(88,89) Strabismus is often 
easily identifiable to parents, even without screening, because it can be noticed 
cosmetically, as opposed to often inconspicuous refractive errors and other eye 
pathology. Clinically, strabismus is often diagnosed with a history and physical 
exam, including the use of corneal light reflexes and cover tests. 
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     The treatment of strabismus will depend on its cause. Treatment of 
accommodative esotropia is usually by correcting the refractive error. Other types 
of strabismus may need to be corrected with surgery, which usually involves 
strengthening or weakening one or more extra-ocular muscles to correct the 
misalignment. Strabismus treatment offers great improvement in psychological 
and physical functioning. (90) 
     Strabismus is thought to account for around 19-25% of amblyopia cases.(2,91) 
Strabismic amblyopia is often less responsive to treatment than other 
forms.(49,92) 
 
2.5.3   Deprivation Amblyopia 
 
     Deprivation amblyopia is amblyopia caused by an obstruction of the visual axis, 
due to an anomaly of any anatomical structure which may disrupt the path of light 
in the eye. Causes of deprivation amblyopia include ptosis, corneal scars, cataracts, 
aphakia or vitreous haemorrhage, or even over-aggressive occlusion therapy for 
treatment of amblyopia of the other eye.(2,93)  
     Obstruction of the visual axis of an eye of a child will mean that there will be a 
lower resolution of images on the retina, causing decreased foveal stimulation. 
This means there is less visual input to process, and so fewer neurons are recruited 
for visual activity. Eventually, if the visual input is sufficiently decreased, normal 
visual development is disrupted, and amblyopia can develop. Deprivation 
amblyopia accounts for about 3-9% of cases.(2,44,94) While rarer, the outcome for 
deprivation amblyopia is generally more severe than other types.  
     Deprivation amblyopia is treated firstly by correcting the underlying cause of 
the deprivation, then treating the amblyopia itself, if required.  
 




     Amblyopia can also be caused by a combination of refractive error, strabismus, 
or deprivation, and this is thought to account for about 27% of cases.(2) 
2.6   Epidemiology of Amblyopia 
 
     Amblyopia is the most common cause of visual impairment in children, and the 
prevalence of amblyopia is variable between populations. It is usually reported as 
being between 1 and 5%(44,95–97), but may differ based on the clinical threshold 
for diagnosis used in the study, the type of testing used, the training of the testers, 
and whether there is a population screening programme. New Zealand specific 
data, obtained from the Dunedin Multidisciplinary Health and Development Study 
(DMHDS), a cohort study following all children born in Dunedin in 1972-3, 
indicated that the prevalence of amblyopia, or having recovered from amblyopia, 
was 6.7%.(98) 
     There is thought to be no sex difference in prevalence of amblyopia.(2) 
Currently, there is little data on the prevalence of amblyopia in Maori or Pacific 
Island children in New Zealand, but children from more deprived backgrounds are 
at a greater risk of having amblyopia.(99)  
 
2.7   Cortical Changes in Amblyopia 
 
     Amblyopia occurs secondary to an abnormality of the eye itself. However, the 
lesions of amblyopia have only been found to occur in the brain, and no evidence 
has been found which suggests there are changes to the retina in 
amblyopia.(100,101) Much of the current understanding of the neuroanatomical 
changes occurring in amblyopia stems from animal studies, particularly landmark 
studies from Hubel and Wiesel. Their studies often examined the brains of kittens, 
usually those which had an eye artificially impaired from birth, such as surgical 
occlusion or permanent deviation of an eye, mimicking the effect of an ocular 
occlusion in children.(33,52,102)    
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     The main areas of the brain affected by amblyopia are the cells in the LGN and 
V1, which are receiving afferent information from the amblyopic eye. LGN cells 
driven by the amblyopic eye are smaller than cells driven by the better seeing eye, 
but these neurons are present in normal numbers and have a normal functional 
response. This suggests that the deficit in the LGN in an amblyopic patient is that 
the neurons here are participating in fewer geniculo-cortical connections, rather 
than the neurons being culled.(32,33) Amblyopic eyes tend to have a normal 
cortical magnification factor and an enlarged population receptive field sizes, as 
well as a disorganised spatial resolution and topography of neurons in V1, meaning 
that the visual system of the amblyopic eye is less adept at performing high acuity 
activities.(103)  
 
2.8   Clinical Features of Amblyopia 
 
     The specific clinical features of amblyopia often depend on the timing of the 
abnormal visual experiences, and the cause of the amblyopia.(104) The main 
feature of amblyopia is a reduction in VA, usually unilaterally, and is thus often 
asymptomatic to the patient.(50) There are also several deficits, clinical and 
subclinical, in visual function in both the amblyopic eye and the fellow eye of 
amblyopic patients.(78)  
     The degree of loss of vision in patients with amblyopia is highly variable, and 
may be categorised as mild, moderate, or severe, a categorisation used by the 
Pediatric Eye Disease Investigator Group (PEDIG), a collaborative network for 
research in amblyopia and other paediatric ophthalmological conditions. PEDIG 
groups amblyopia in the following categories (table 1): 
  
Mild Amblyopia VA of 6/9 to 6/12 in the amblyopic eye 
Moderate Amblyopia VA of 6/12 to 6/24 in the amblyopic eye 
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Severe Amblyopia VA of worse than 6/24 in the amblyopic eye 
Table 1: PEDIG Categories of Amblyopia Severity 
Around 25% of amblyopia cases would be classified as severe.(105)  
     Amblyopic patients have some degree of extrafoveal fixation, or eccentricity, 
and more severe cases of amblyopia tend to have a greater distance of fixation 
from the fovea. The fovea is the retinal location of a high density of cones, and is 
thus the area responsible for high visual acuity. Eccentric fixation is a sign of 
severe amblyopia, and often carries a poor VA prognosis.(106) 
     The crowding phenomenon is a physiological feature demonstrated by patients 
with amblyopia, whereby they demonstrate a worse VA when reading multiple 
optotypes than if reading single optotypes. This phenomenon can be elicited using 
crowding bars around optotypes, or vision-charts with multiple optotypes. The 
crowding phenomenon is due to the relatively large sensory-receptive field of the 
retina, which occurs in amblyopia, meaning there are fewer neurons being driven 
by the amblyopic eye, and thus each of those remaining neurons becomes 
innervated by a larger proportion of the photoreceptive area of the retina. The 
clinical implication of this is that eye charts using crowding bars can be more 
sensitive in the diagnosis of amblyopia, and thus should be used in clinical practice 
to not underestimate the severity of VA loss in amblyopia.(107) 
     Also, both stereoacuity and contrast sensitivity tend to be reduced in amblyopes. 
Stereoacuity is a measure of the smallest difference in depth that can be perceived, 
and is usually absent in strabismic amblyopia, and reduced in other types. (108) 
Contrast sensitivity is the ability to distinguish objects of different colours and 
brightnesses, and people with amblyopia will require more contrast to detect 
certain stimuli compared to those without amblyopia.(109) 
 




     There are several ways to diagnose amblyopia, such as VA, stereoacuity, and 
contrast sensitivity. VA measurement is the most commonly used method, as it is 
readily available, as well as readily understood by most patients and examiners. 
Unlike other methods, it also requires minimal specialised equipment and is 
relatively portable.(43)  
     VA testing is a test of how well the visual system can resolve spatially distinct 
objects, and aims to determine the minimal angle where this resolution can occur, 
the minimal angle of resolution (MAR). Each optotype, usually a letter or figure, 
contains critical details: discrete components that must be discerned to allow 
identification of that optotype. VA can be noted in Snellen Fractions or in logMAR 
units. In Snellen Fractions, the denominator denotes the furthest distance at which 
the patient can identify the optotype (often 6 metres), and the numerator denotes 
the distance at which most people with normal vision can identify the same 
optotype, allowing an instant comparison of the patient with the normative values. 
VA can also be recorded in logMAR units, which is the logarithm 10 of the minimal 
angle of resolution, where the normal MAR is 1 minute of arc. logMAR units allow 
statistical analysis of VA scores that cannot be achieved with Snellen Fractions.  
     Visual acuity testing is ideally performed with optotypes surrounded by 
confusion bars which linearly decrease in MAR, and is high contrast, with black 
letters on white charts. Figure optotypes have an advantage over letter optotypes 
for paediatric patients who may be preliterate.(110) A range of visual acuity charts 
are used in clinical practice, and several examples are outlined below (table 2). The 
child may be asked to name the figure or letter shown, or, in younger children, 
asked to match the figure or letter shown to example figures/letters held by an 
assistant (often the child’s carer) before the child.  
 
 




Allen Pictures  
 
Wright Figures  
 













Parr Letter Matching 
 
Table 2: Types of VA Tests 
 
     Stereoacuity can be tested with a stereogram, exposing each eye to two different 
panels of an image, by superimposing them with a stereoscope. If each eye is 
functioning normally, then the image should be perceived as having depth. In 
children, stereoacuity is often tested with the ‘Titmus fly test’, where a 
stereoscopic image of a fly is used, and if there is a sufficient level of stereoacuity, 
the observer can perceive the image through polarised glasses (of perpendicular 
axes) as three-dimensional, particularly the translucent wings of the fly.(111) 
     Contrast sensitivity can be measured by testing a patient’s ability to differentiate 
between increasingly similar contrasts. Individuals with reduced contrast 
sensitivity will require two points to have an increased difference in the level of 
the colour and brightness to be distinguished, compared to an individual with 
normal contrast sensitivity. Amblyopes have been found to have a reduced level of 
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contrast in both eyes, and so assessment of contrast sensitivity function may be 




2.10   Treatment of Amblyopia 
 
2.10.1   Timing of Treatment 
     While most cases of amblyopia are treatable, this treatment must be within the 
critical period of visual development, before there are irreparable changes to the 
visual cortex. Earlier treatment of amblyopia has a better outcome due to the 
higher level of plasticity in the visual.(113) The plasticity of the cortico-visual 
centre in children diminishes as they age, and treatment is often ineffective in 
children once they are past around 9 years of age.(49) This means that earlier 
detection is important for the effective treatment, and suggests that the screening 
of amblyopia at the population level could be useful for providing timely treatment 
to patients. Earlier treatment also means that a shorter treatment duration is 
needed to achieve the same outcome.(41) However, there are cases of 
improvement in VA following treatment in older children, adolescents and adults 
with amblyopia after the classically taught critical period of visual 
development.(38,114) This suggests that during the development of amblyopia 
neurons are suppressed rather than destroyed, and the visual system retains some 
plasticity.(48) 
 
2.10.2   Treatment of Underlying Cause 
 
     The first principle of treatment of amblyopia is correcting the underlying cause. 
Refractive errors can be corrected with spectacles or contact lenses, strabismus 
can be treated by correcting any underlying refractive error, or correcting the 
misalignment with surgery, and media opacities should also be treated as soon as 
possible. Managing the underlying cause of amblyopia means that the disease is 





2.10.3   Penalisation therapy 
 
     The second aspect of amblyopia treatment is increasing usage of the amblyopic 
eye. This is achieved by suppressing the use of the ‘better’ eye, either via occlusion 
with patching, or by blurring it with the use of atropine drops, which acts to 
reverse the competitive developmental advantage that the non-amblyopic eye has 
had. Atropine works by limiting the ability for the better seeing eye to 
accommodate, so near-visual activity will be obligated to be with the amblyopic 
eye. Increasing use of the amblyopic eye will mean that there is an increased 
stimulation of the cortical areas associated with the amblyopic eye, which can help 
reverse the delayed development in the visual cortex. Occlusion therapy with 
patching of the better eye has been the mainstay of amblyopia treatment for many 
years.(116) 
     Some cases of refractive amblyopia may resolve with optical correction alone. 
However, occlusion therapy in conjunction with spectacles for refractive 
amblyopia has been found to be more effective than the use of spectacles 
alone.(115) The efficacy of both patching and atropinisation is comparable, and 
have visual acuity improvements of similar magnitude.(117,118) Atropine has the 
added advantage of being able to penalise the eyes of children who are not 
compliant with patching. Penalisation is effective in treating all three types of 
amblyopia.(119) 
     The duration of occlusion therapy is most effective within around the first 400 
hours of occlusion. Full time and part time patching have similar outcomes, 
however, there is often a higher rate of compliance in children who have full time 
penalisation, since parents are less likely to forget during full time therapy.(120) 
 
2.10.4   Outcomes of Amblyopia Treatment 
 
     Successful treatment can be achieved in up to 80% of patients, but the outcome 
is dependent on initial visual acuity, type of amblyopia, binocular status, level of 
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fixation, compliance and duration and timing of treatment.(100,106) While the 
rate of improvement of VA is slower for older patients than younger ones, there is 
little correlation of age at start of treatment with final visual acuity that can be 
achieved in amblyopia treatment.(105,121,122)  
     In general, children with combined-mechanism amblyopia may have a worse 
prognosis, even despite treatment.(122,123) This is probably because multiple 
causes will worsen the severity of the amblyopia. There is a strong correlation 
between the initial visual acuity and the best visual acuity that can be obtained 
from amblyopia treatment.(72,105) Treatment is worthwhile in children with 
severe amblyopia, but in cases of mild unilateral amblyopia there may be little 
benefit.(124). The PEDIG found that 2 hours of occlusion therapy for moderate 
amblyopia was just as effective as full-time occlusion, and improved VA to 6/9 in 
62% of patients with moderate amblyopia.(116) The PEDIG also found that 6 
hours of occlusion therapy was just as effective as full-time occlusion in severe 
amblyopia patients, and was able to improve VA by more than 4 lines on average in 
these cases.(125) 
 
2.10.5    Adverse Effects of Treatment 
 
     While treatment can be associated with some distress to the child, there is often 
no effect on child’s well-being or behaviour during or after treatment.(126) 
Children with amblyopia who do not receive treatment are at risk of their VA 
deteriorating, or at least not improving on its own. A potential adverse outcome of 
amblyopia treatment is over-treatment, with too much occlusion of an eye. This 
can cause amblyopia in the patched eye, due to deprivation of that eye’s visual axis 
during the critical period over-suppressing development of the better-seeing eye. 
Therefore, it is important to monitor both eyes of a child undergoing amblyopia 




2.11   The Functional Impact of Amblyopia 
 
     An important and controversial topic is the functional impact of amblyopia. 
There are many studies which have examined this, and looked at long term 
outcomes of amblyopia in factors such as motor skills, psychological functioning, 
education, employment, and socio-economic status (SES).(98,128,129)  
     Vision is an important sensory stimulus for a developing child. Amblyopia, with 
its unilateral visual impairment, could possibly hinder the development of other 
complex functions in children, such as motor development. It may affect the 
acquisition of skills such as grasping, hand-eye coordination, walking, and balance. 
It has been found that children with amblyopia may have a reduction in some fine 
motor skills, compared to normal children, particularly in tasks that require speed 
and accuracy.(45,130) Monocular vision in otherwise normal individuals is also 
associated with a decrease in perception of velocity, increased reaction time, and 
worse at performing prehensile actions compared to those with binocular vision, 
suggesting that amblyopia may lead to issues with motor skills.(100,129)  
     Also, amblyopes have been found to have a slower reading speed than non-
amblyopes, but this did not necessarily correlate to a difference in academic 
achievement.(129)  There is some evidence that amblyopia has a significant effect 
on psychosocial functioning, with difficulties relating to an individual’s self-image, 
work, school, and friendships.(130,131) However, amblyopia is thought to not 
impact on lifetime occupational class.(3) 
     A study arising from the DMHDS found that people with amblyopia or having 
recovered from amblyopia had no difference in motor skills in children, self-
esteem in adolescence, or socio-economic status and education in adulthood. This 
suggests that amblyopia may not have such adverse outcomes on the day to day 
lives of patients.(98)  
     An important consideration with amblyopia is that if an amblyope loses vision in 
their better-seeing eye, such as from trauma or other eye pathology, they will have 
low vision in both eyes. This is far more disabling than the otherwise unilateral 
34 
 
vision loss that would occur in someone with normal vision losing vision in one 
eye. Amblyopes are at an increased risk of vision loss in their better eye, where the 
risk may be as much as three times greater.(3) More than half of the causes of 
visual impairment in the better eye is trauma.(132) A possible reason for this 
increased risk in amblyopes is that there are subclinical cortical deficits and visuo-
cortical instability of the better seeing eye, and so the ‘normal’ eye may be at more 
susceptible to injury.(133) 
     While there is a risk of bilateral visual impairment in amblyopes who lose vision 
in their better-seeing eye, a study has found that 10% of people with amblyopia 
who had lost vision in the better eye had a significant improvement in the VA of 
their amblyopic eye.(3) The mechanism for this is not fully understood, but does 
suggest that the visual pathway in some people may retain the ability to adapt long 




Chapter Three - Childhood Vision Screening 
 
3.1   What is Screening 
 
     Screening is a process to identify medical conditions in a population who may be 
asymptomatic, identifying individuals who have a condition in its early stages, 
before it would otherwise become apparent. Screening allows earlier intervention 
than would otherwise be possible, which usually leads to better health outcomes. 
Screening tests are not intended to be diagnostic, but instead identify those who 
are likely to have the disease to help guide further investigations.  
 
3.2   Validity of Screening 
 
     The result of a single screen is either positive, i.e. the patient is suspected to 
have the disease, or negative, i.e. the patient is expected to not have the disease. 
This presents four possible outcomes of a single screening test: truly positive (TP), 
falsely positive (FP), truly negative (TN), or falsely negative (FN). 
     Sensitivity is the measure of how likely that those who have the disease will 
have a positive screen. A high sensitivity means that cases of the disease are less 
likely to be missed.  
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 = 𝑇𝑃 /(𝑇𝑃 + 𝐹𝑁) 
 
     Specificity is the measure of how likely that those who do not have the disease 
will have a negative screen. A high specificity means that there will be fewer of 
people without the disease having positive screens.  




     Positive Predictive Value (PPV) is how likely an individual who is screened as 
positive will have the disease.  
𝑃𝑃𝑉 = 𝑇𝑃/(𝑇𝑃 + 𝐹𝑃) 
 
     Negative Predictive Value is how likely an individual who is screened as 
negative will not have the disease.  
𝑁𝑃𝑉 = 𝑇𝑁/(𝑇𝑁 + 𝐹𝑁) 
 
     Screening programmes with high sensitivity, specificity, PPV, and NPV are more 
reliable, and will have fewer cases of false screening results.  
 
3.3    Requirements for a Screening Programme 
 
     Not all medical conditions are suitable candidates for population screening 
programmes. In 1968, Wilson and Jungner described 10 principles for screening 
programmes in their work Principles and Practice of Screening for Disease, which 
are outlined in the textbox below, and have become widely used to guide the 
implementation of population screening programmes throughout the world.(134) 
1. The condition should be an important health problem 
2. There should be an accepted treatment for the condition 
3. There should be facilities for diagnosis and treatment available 
4. There should be a latent stage of the disease 
5. There should be a suitable test or examination for the condition 
6. The test should be acceptable to the population 
7. The natural history of the disease should be adequately understood 
8. There should be an agreed policy on whom to treat 
9. The total cost of finding a case should be economically balanced in relation 
to total medical expenditure 






These principles have been widely considered the standards for judging screening 
tests.(135) 
 
3.4   Why There Should be an Amblyopia Screening Programme in New 
Zealand 
     Many societies, including New Zealand, have adopted some form of childhood 
vision screening for the detection and treatment of amblyopia. Amblyopia is 
generally asymptomatic and requires treatment during the critical period of visual 
development. A potential screening programme disease should meet the principles 
outlined by Wilson and Jungner to be implemented, and thus these principles, as 
applied to amblyopia, are outlined below.  
 
3.4.1   Amblyopia as an important health problem 
     Important health problems include conditions with a high prevalence, as well as 
presenting severe enough consequences to the individual or community. 
Incredibly rare or rather mild disease are therefore not necessarily suitable for 
screening programmes. Amblyopia is an important and relatively prevalent health 
problem: it is most common cause of unilateral visual impairment in the first four 
decades of life. Of note, however, the functional impact on an untreated individual 
later in life is perhaps less certain, as described previously. Nonetheless, amblyopia 
can have a major effect on a patient’s vision if they also have vision loss in the 
better-seeing eye later in life, leaving only an amblyopic eye for vision.  
 
3.4.2    Accepted Treatment of Amblyopia 
     It is neither ethical nor a prudent use of resources to screen for diseases which 
are not able to be treated. Also, the treatment for a screened disease should be 
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more effective during the pre-symptomatic, border-line stage than in its late 
stages, to justify the need to treat the disease sooner.  
     Amblyopia is treatable, treated by correcting the underlying cause of the 
amblyopia, and with penalisation of the better eye, with patching or atropine, often 
with positive results. This therapy must occur before the critical period of visual 
development. This suggests that detecting cases by screening can allow earlier, and 
thus more efficacious, treatment.  
 
3.4.3   Facilities for Diagnosing and Treating Amblyopia 
     If a society is to adopt a population screening programme, it must have the 
resources to treat all cases of the disease detected through screening: it is not 
ethical to invest in screening programmes when there is no follow-up for 
suspected cases. Many health professionals can diagnose and treat amblyopia, 
including nurses, general practitioners, optometrists, orthoptists, and 
ophthalmologists.  
3.4.4   Latent Stage of Amblyopia 
     If a disease is to be screened it should have a latent stage, where symptoms are 
not present, but the disease is still able to be detected if it is specifically tested. If 
the first indications of a disease are symptoms, patients and clinicians will be 
aware there is a disease regardless of the screening. Amblyopia is a developmental 
disorder, and during earlier stages of the disease symptoms are milder, and thus 
has a period of latency. If left untreated, the severity of amblyopia can worsen, and 
the ability to treat diminish. 
 
3.4.5   Suitable Test for Amblyopia 
     Screening tests need to have an acceptable level of validity to be able to find 
cases of the disease, and rule out those which are not likely to be cases of the 
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disease. This means minimising the number of FP, so that fewer patients are 
subjected to unnecessary investigations and worry, and minimising the number of 
FN, so that fewer cases of disease are missed and fewer patients have a false sense 
of security. 
     There are several ways of testing for the presence of amblyopia. The clinical 
features of amblyopia include reduced VA, reduced CS, and reduced stereoacuity, 
and measurement of these could be used to identify potential cases of amblyopia. 
VA testing is useful, as it is portable and relatively easy to perform, even without 
significant training, and is thus the preferred method of screening for most 
populations.  
     However, a range of factors may affect VA testing, such as lighting, type of test 
chart, distance from the chart, and experience of the examiner, and these may 
influence the accuracy of the test, which means that there may be a relatively high 
proportion of falsely positives and falsely negative results from the 
screening.(136,137) There is a tendency for many paediatric vision screening tests 
to have a large proportion of false positive results, possibly because children may 
be uncooperative or easily distracted, meaning that a lot of children are detected as 
having amblyopia in screening, but turn out to not have anything wrong with their 
vision.(138–140) This can mean there are financial costs with health care 
professionals seeing patients unnecessarily, and opportunity costs of other 
patients possibly being delayed in accessing those health care professionals.  
 
3.4.6   Acceptability of Amblyopia Screening to the Population 
     A test in a screening programme needs to be acceptable to the population to 
which it is offered. This requires the population having an adequate education 
about the disease, and the testing not being too discomforting or upsetting to the 
population. A screening test should be quick and easy to perform, and minimise 
discomfort to the patient. Screening tests that difficult or distressing to the patient 
may not be well tolerated by the population. Most vision screening consists of 
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measuring VA, which is not particularly distressing to most patients, including 
children. Most parents/caregivers are also aware of the importance of vision, and 
are happy for their children to participate in a vision screening programme.  
 
3.4.7   Natural History of Amblyopia 
     It is important to understand how a disease progresses and what effect it can 
have, so that the detection of early signs in screening can be accurately correlated 
to the later, symptomatic stages. Most knowledge about the natural history of 
amblyopia comes from animal models, and there has been little research directly 
assessing the natural history of amblyopia, due to ethical concerns.(127) However, 
once the critical period is reached and if the disease not treated, the severity of the 
visual acuity loss usually stays the same.(141)  
 
3.4.8    Agreed Policy on Amblyopia Diagnosis and Treatment 
     For a screening programme to function properly, there needs to be clear 
guidelines on what cases should receive further investigations or treatments. If 
clinicians have differing protocols for when to treat the same condition, some cases 
identified in screening may or may not be treated, depending upon the preferences 
of a patient’s clinician.  
     As there is a range of clinical definitions of amblyopia, including differing levels 
of VA which constitute amblyopia, a screening programme would need to adopt a 
fixed criterion for which patients will be screened as positive, for example, a VA of 
6/9 in one eye.  
     High quality evidence exists for the treatment of amblyopia using penalisation 
therapy, and this forms the basis for evidence-based practice by treating 
orthoptists, optometrists, and ophthalmologists.(47,108) However, treatment of 
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amblyopia will still depend on the clinician’s clinical judgement, and there is no set 
guideline for this in New Zealand. 
 
3.4.9   Cost-effectiveness of Amblyopia Screening 
     If screening can significantly increase a society’s economic situation, or avoid 
huge economic cost, then this is a good thing. However, if the cost of screening 
proves to be more expensive than the disease would be, the economic benefit of 
screening is questionable. The cost of finding a case of amblyopia should be 
weighed in relation to the economic cost of a case of amblyopia itself. Costs 
associated with a vision screening programme include the employment of those 
administering the screening, including salary and transport, as well as the cost of 
management and administration of the screening programme. 
     As most cases of amblyopia feature a unilateral reduction in vision of one eye, 
the cost of a higher prevalence of amblyopia in society largely depends on the long-
term effect of this unilateral vision loss, which, as discussed, may not have such a 
significant impact on the individual’s functioning. Also, if a vision screening 
programme is not completely accurate and has a large proportion of false positive 
and false negative results, then the screening is not maximising the number of 
cases of amblyopia it is detecting, and may be expending too many resources in 
referral pathways for ‘normal’ patients.  
     Thus, while treatment of amblyopia is considered effective, the cost 
effectiveness of vision screening and treating a case of amblyopia is still 
controversial, and so several studies have analysed the cost-effectiveness of 
amblyopia screening, comparing the cost to the Quality-Adjusted Life Years (QALY) 
gained. A National Health Service review in the United Kingdom (UK) into the cost-
effectiveness of amblyopia screening in the UK for children aged between 4 to 5 
years found that screening is not likely to be cost-effective at accepted values of a 
QALY, compared to other screening programmes.(142) A study of vision screening 
cost-effectiveness in Germany indicated that the cost of finding one case of 
42 
 
amblyopia ranges from about USD $650-1630.(143) Another study in the United 
States in 2012 found that VA and stereoacuity screening of children in 
kindergarten had a cost of USD $17,000-21,000 per QALY gained, and while being 
comparable in cost to multiple other public health programmes, was also found to 
be less cost-effective than no amblyopia screening at all.(144)  
  
3.4.10   Amblyopia Screening as a Continuous Process 
     Screening needs to be happening continuously. Without continual screening, 
only the small population who is screened will receive the benefits of screening, 
and thus the screening will not affect the future incidence. Also, continuous 
screening allows the screening organisation to become more efficient and 
proficient.  
     A population vision screening test can be performed on each target 
demographic multiple times at different ages, and for different groups continually 
over time, so that the screening can be a continuous process. 
 
3.4.11   Suitability of a Screening Programme for Amblyopia 
     One might think that a disease like amblyopia, where timely treatment is 
paramount to the success of the treatment, where it is relatively common in 
society, but without patients presenting with symptoms, and where there may be 
associated effects to the development of a child with amblyopia, would be an ideal 
candidate for a public health screening programme. Indeed, an amblyopia 
screening programme appears to meet many of the screening programme 
guidelines outlined by Wilson and Jungner: amblyopia is treatable and there are 
facilities to treat it, it has a latent stage, there are suitable tests for screening, 
testing is acceptable to the population, the natural history of it is understood, there 




     However, there is still debate in literature regarding paediatric vision screening, 
and there is substantial support of discontinuing many vision screening 
programmes.(145–148). The controversy surrounding amblyopia screening 
programmes largely stems from the uncertainty of how much of a public health 
issue and economic burden the disease is, and whether is it severe enough to 
warrant a screening programme for it, the uncertainty of how well a vision 
screening programme can reliably and accurately detect cases of amblyopia (and 
cases of normal vision), and the uncertainty of how cost-effective the endeavour of 
screening truly is. If a society is going to have a population screening programme 
for amblyopia, it should ideally address these issues first, and therefore there 
needs to be more research into these areas.  
 
3.5   When to Screen for Amblyopia 
 
     Childhood vision screening needs to occur before the critical period of visual 
development, meaning all cases should ideally be identified before 7 years of age, 
for treatment to be effective. However, if screening occurs too early vision testing 
will be more prone to performance artefact, and there is a risk of missing cases of 
amblyopia that may develop after the screening. It has been suggested that the 
optimal age for screening for strabismic amblyopia is 12-18 months.(92) However, 
screening all high-risk children up to the age of one year only identifies about one 
third of amblyopia cases.(143) 
     One study found that children being treated for amblyopia are four times as 
likely to remain amblyopic if they are only screened at 37 months, compared to 
those screened both at 8 and 37 months, which suggests that multiple screening 
may optimise detection of amblyopia cases.(149) It has also been found that 
children screened for amblyopia at 5 years of age did not have a reduced potential 
for improvement compared to children screened at younger ages.(150) Screening 
around this age would be a good compromise, as it allows sufficient time to treat 
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amblyopia, while also being late enough to minimise the number of cases missed 
or developing after screening.  
3.6   How to Screen for Amblyopia 
 
     Amblyopia usually features a unilateral reduction in VA, and so one obvious way 
to screen for amblyopia is by measuring the VA of each eye with an eye chart. This 
method of testing is relatively simple, and can be administered by people without 
necessarily needing advanced training. Other advantages of VA testing include it 
being relatively well understood and accepted by the general population.   
     It has been suggested that childhood vision screening should include the use of 
autorefraction alongside VA testing, to allow the detection of suspected refractive 
error as well, such as high hypermetropia, which may not present with a decreased 
VA, as the child is still able to accommodate, but can cause other visual problems 
later.(110) 
     Another method of childhood vision screening is photoscreening, with the use of 
a photoscreener, a non-invasive device that takes images of a patient’s eyes, and 
can measure refractive state, the pupil size and distance, and the gaze deviation. 
Advantages of photoscreening include it being quick and easy to perform, with the 
patient only needing to be attentive for a few seconds. However, there are several 
disadvantages, such as it being a relatively expensive piece of equipment, and often 
needing a trained specialist to interpret some of the results. Photoscreening may 
be a cost-effective way of population screening, and some photoscreeners have 
relatively high levels sensitivity and specificity, for example the Plusoptix Vision 
Screener (Plusoptix, Germany), which has a sensitivity of 98%, and a specificity of 
69%.(151) These types of devices may allow the detection of amblyopia risk 
factors, without needing an ophthalmologist to administer the exam.(152,153) 
     Other methods of amblyopia screening include measuring optokinetic 
nystagmus and Visual Evoked Potentials. Using these tests as a part of a screening 
programme do present some issues as they are usually more difficult to 




3.7   Examples of Societies with Some Form of Vision Screening 
 
     Following Hubel and Wiesel’s elucidation of the development of amblyopia, 
many populations adopted and have continued to practise some form of vision 
screening. Several examples of societies with childhood vision screening 
programmes, and the methods used for screening (table 3).(156)  
 
Country (State) Method of Screening 
Australia (New South Wales) 
 
VA in 4 year olds with 6m linear chart 
(157) 
 
Australia (Victoria) VA in 3.5 year olds with letter 
matching at 3m (158) 
United Kingdom VA in 4-5 year olds with linear chart 
(159) 
United States of America (California) VA testing at 5 years with linear chart 
at 6m (160) 
Japan VA testing at 3 years with Landolt ring 
at 2.5m at home (161) 
Sweden VA testing at 4 years HOTV chart at 3m 
(162)  
Table 3: Socities with and Methods of Childhood Vision Screening 
     There are several countries that do not have a standardised national vision 
screening programme, such as Canada, Spain and Switzerland.(156) Also, there are 
different vision screening programmes in use in Australia, between various states 
and territories, which do lack coordination and national guidelines on when and 
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how to screen. A lack of consensus does mean it is both difficult to analyse the 
efficacy of this screening, and there may be a significant number of children not 
being screened, as providers of various screening programmes are not aware of 
which children have already been screened elsewhere.(163) 
     The United Kingdom national guidelines suggest using an orthoptic led 
screening programme to detect visual impairment in children aged 4 to 5 years, 
and this has been found to be accurate, with a positive predictive value of 
86%.(164) Vision screening in Germany has been found to have a sensitivity and 
specificity of an orthoptic led screening programme was 90.9% and 93.8%.(165) 
Both cases imply that screening for reduced VA in children carried out by eye care 
professionals may allow for high levels of accuracy, compared to other health 
professionals. It has also been found that in Israel the prevalence of amblyopia in a 
screened population was 1.0%, compared with the prevalence of amblyopia in an 
unscreened population of 2.3%, suggesting that screening does indeed reduce the 
amount of amblyopia in a population.(166)  
     In the Netherlands, a large prospective study, following a cohort of 3000 
children from birth, found that only around half of those children with amblyopia 
were identified by the vision screening programme. This suggests that vision 
screening may not be hugely sensitive, and raises further questions over its 
reliability.(167) 




3.8   The B4 School Check 
 
     The first part of childhood vision screening in New Zealand occurs through the 
B4 School Check. The B4SC is a nationwide programme aimed at screening for a 
range of health issues in children before they reach school, such as vision, hearing, 
and development. The purpose of the vision screening is to identify any children 
who have amblyopia, at an age where it is still treatable. 
     Vision screening is administered by vision hearing technicians (VHTs): trained 
personnel who undergo continued professional development, as well as routine 
assessment of competence. These VHTs work in the community to screen children 
for vision and hearing problems, usually once the child turns 4, and ideally before 
the child’s 5th birthday. The screening often occurs in a school or kindergarten, but 
may occur at the child’s home if necessary.  
     The B4SC guidelines for vision screening (appendix A) employ VA testing with 
Parr Letter matching, with confusion bars, at 4 metres. The B4SC vision screening 
is identifying children with decreased VAs, which may result from amblyopia, 
refractive error, or other eye pathology, and thus, analysis of the accuracy of the 
testing of the B4SC vision screening programme should consider all causes of low 
vision as a true positive referral.  
     The threshold for a positive screen, resulting in a referral, is a VA of 6/12 or 
worse in either or both eyes. A VA of 6/9 in one eye and 6/6 in the other will result 
in repeating the screening a later date. If there is a decrease in VA, or no 
improvement on rescreening, then that child will be referred. If the screening 
result from the rescreen is 6/6 in each eye, that child will pass the screening.(42) 





Figure 5: Referral pathway for the B4SC 
 
3.9   Efficacy of the B4SC 
 
     For the B4SC to be optimal in detecting vision defects in a population, it must 
screen most, if not all, of the population, as well as the testing being accurate, 
meaning there will be very few cases of undiagnosed amblyopia in the community, 
and there are very few instances of people being falsely screened as having 
amblyopia.  
     There has been one review into the efficacy of the B4SC vision screening, by 
Langeslag-Smith, who studied the programme in Counties-Manukau DHB.(168) 
This study, looking at all children who failed vision screening in one year, found 
that screening produced high numbers of false positive referrals, resulting in a 
positive predictive value of only 31%. This suggests that the VHTs are likely to 
over-refer, when there may not be a vision problem. This may be due to the 
training of the VHTs, the Counties-Manukau population including a large 
proportion of international children who may not necessarily be able to 
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communicate well with the VHTs, as well as the nature of testing 4-year-olds, who 
may not comply with the vision screening, or may otherwise interfere with the 
screening process. The implication for this high PPV is that the B4SC is more costly 
and inefficient than it otherwise could be, since it is referring many ‘normal’ 
children into eye care services. Optimised efficiency of vision screening would 
mean fewer unnecessary referrals to DHBs and optometrists, which could lower 
health care costs, and help unburden already stretched services. 
     The negative predictive value found in this study was 92%, which is high 
enough to suggest that most cases are detected. This value was calculated in a 
sample of children who were referred from the B4SC to the DHB eye clinic, and 
were found to have a reduced VA in one eye, but compared to the VA values from 
the eye with a normal VA to the B4SC VA result for that eye. It was noted, however, 
that altering the criteria for a positive screen from a VA of 6/9 in either eye to 6/12 
would improve the PPV, without adversely affecting the NPV, meaning that altering 
the B4SC criteria to only refer children with 6/12 or worse in either eye could 





Chapter Four - Aims 
4.1   Primary aim 
 
1. To determine the false positive, false negative, positive and negative 
predictive values of the childhood vision screening component of the B4 
School Check in Southern and Tairawhiti DHBs for amblyopia and/or 
refractive error. 
- Where amblyopia and/or refractive error are defined as a visual acuity 
of 6/9 or worse in at least one eye, or 6/12 or worse in both eyes 
o [This definition selected to match the criteria that will 
result in a referral for further optometric/ophthalmic 
examination by the B4SC Vision Screening Program.] 
 
 
4.2   Secondary aims 
 
1. To determine the prevalence of amblyopia and/or refractive error in 4-7 
year old children in Southern and Tairawhiti District Health Boards 
2. To describe the causes of amblyopia and nature of refractive errors in 4-7 
year olds in Southern and Tairawhiti DHBs 
3. To compare and contrast the incidence of amblyopia and/or refractive 
error between Southern and Tairawhiti DHBs, including analysis of possible 
relationships with ethnicity and socio-economic deprivation.  
4. To determine the post-referral pathway of children who fail the vision 
screening component of the B4SC 
a. Choice of and attendance at an eye healthcare provider 
b. Management of amblyopia and/or refractive error 
5. To describe the characteristics of children diagnosed with amblyopia 




Chapter Five - Methods 
 
     This study was a retrospective audit, and analysed the children who had been 
screened for vision between 1 April 2016 and 30 September 2016, by the B4SC, in 
both the Southern and Tairawhiti DHBs. A referral from the B4SC vision screening 
programme, which is defined as a VA of 6/9 or worse in one eye, or 6/12 or worse 
in both eyes, can lead to follow up assessment with either an optometrist, local 
DHB eye clinic, or a private ophthalmologist. Data from the B4SC was compared to 
data collected from Southern and Tairawhiti DHB eye clinics, and to data collected 
from community optometrists in the Southern and Tairahwhiti regions. 
Clinical data was obtained from three sources: 
• B4 School Check database. 
• Clinical records of Southern and Tairawhiti DHB eye clinics. 
• Community optometrists in the Southern and Tairawhiti DHB regions.  
 
5.1   Inclusion Criteria 
 
     All children screened for vision by the B4SC in either Southern or Tairawhiti 
DHB, between 1 April and 30 September 2016, as well being seen at either:  
• a community optometrist between 1 April and 31 October 2016 or,  
• a DHB eye clinic in SDHB or TDHB between 1 April and 30 November 2016. 
 
5.2   B4SC database 
 
     Information on children who were screened for vision with the B4SC in 
Southern and Tairawhiti DHBs was collected from the Ministry of Health. Only the 
identifying information (i.e. name, date of birth, and NHI number), date of the 
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screen, and the results of the screen (i.e. pass, fail, or rescreen) were collected. 
 
     Of the children screened within the study period and meeting the criteria for 
inclusion (by presenting at a community optometrist or DHB eye clinic) the 




- Visual acuity of right and left eyes from screening 
- Referral status 
- Any follow-up data from referrals 
 
 
5.3   Southern and Tairawhiti DHB clinical records 
 
     Clinical records of all children aged 4-7 years seen at Southern and Tairawhiti 
DHBs (Southland, Dunedin and Gisborne Hospitals) between 1 April and 30 
November 2016 were collected. This longer data collection period was to allow for 
the delay between referral from the Vision Hearing Tester and First Specialist 
Assessment (FSA) at the relevant hospital. 
     A list of children aged 4-7 who had been seen during the study period was 
created using patient management software, and their NHI number was recorded. 
Patient notes were then collected for the appropriate children. From the patient 







     This information was used to crossmatch children to the list of those screened 
from the B4SC database. Children seen at Southern and Tairawhiti DHBs who were 
screened by the B4SC programme between 1 April and 30 September 2016 were 
de-identified and the following additional clinical information from the patient 
notes was recorded: 
 
- Source of referral where applicable (e.g. VHT, GP, optometrist, DHB) 
- Visual acuity of each eye 
o Unaided and Best Corrected as applicable 
o Specifying which visual acuity test used 
- Cause of visual impairment (if any) 
o Refractive error 
o Amblyopia 
▪ Strabismic, pattern deprivation or refractive  
o Ocular pathology 
- Ophthalmic examination findings 
o Cycloplegic refraction 
o Ocular pathology 







     No further information regarding children seen at Southern and Tairawhiti 
DHBs who were not screened by the B4SC programme between 1 April and 30 





5.4   Community optometrist clinical data 
 
     We approached and engaged with local community optometrists in Otago, 
Southland, and the Gisborne area. Clinical data regarding all children aged 4-7 
years seeing an optometrist between 1 April and 31 October 2016 was recorded. 
This longer data collection period was to allow for the delay between referral from 
the Vision Hearing Tester and the arrangement of an appointment with an 
optometrist by the child’s parent or caregiver. 
 
     There were several methods used to collect data from community optometrists. 
Practices either regularly emailed clinical records with the appropriate 
information as relevant children were seen, filled in copies of the optometrist data 
sheet (appendix B) to be collected by the student researcher, or recorded a list of 
names of children who had been seen, and allowed the student researcher to 
review their notes, depending on practice resources and clinician preference.  
 
     In each case, the following information was recorded:  




     This information was then used to crossmatch children to the list acquired from 
the B4SC database. Children seen by an optometrist who were screened by the 
B4SC programme between 1 April and 30 September 2016 were de-identified and 
the following additional clinical information was recorded: 
 
- Date of appointment 
- Source of referral (e.g. VHT, parent, GP) 
- Visual acuity of each eye 
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o Unaided and Best Corrected as applicable 
o Specifying which visual acuity test used 
- Cause of visual impairment (if any) 
o Refractive error 
o Amblyopia 
▪ Strabismic, pattern deprivation or refractive  
o Ocular pathology 
- Ophthalmic examination findings 
o Cycloplegic refraction where possible 
o The presence of any pathology  
- Management  
o glasses 
o penalisation 




     No further information regarding children seen at their optometrist who were 
not screened by the B4SC programme between 1 April and 30 September 2016 
was collected, and their clinical records were deleted from the study’s database. 
 
5.5   Variables 
 
     The variables measured this study were: 
- Screening Outcome from B4SC (pass, fail, or rescreen) 
- B4SC tested VA in the left and right eyes (logMAR) 
- Optometrist, DHB, or private ophthalmologist tested VA in the left and right 
eyes (logMAR) 
- Presence of amblyopia (defined as logMAR > 0.3) 
- Presence of refractive error 
56 
 
- Cycloplegic refraction in each eye 
- Presence of any ocular pathology 
- Management 
 
5.6   Data analysis 
 
     Identifying details of all children included in this study were cross-matched 
between data sources (B4SC, DHB, and optometry practices), for both Southern 
and Tairawhiti DHBs. Subsequent data analysis was only be performed on children 
screened by the B4SC programme between 1 April and 30 September 2016 in 
Southern and Tairawhiti DHBs, utilizing data available from all sources as collected 
above. 
 
     All visual acuity scores were converted to logMAR units for statistical analysis. 
Descriptive statistics of all data variables were calculated for each data source, to 
allow the estimation of the proportion of screenings resulting in referral, as well as 
estimation of prevalence of amblyopia, refractive error, and other ocular pathology 
in the study population.  
 
     Visual acuity scores obtained from the B4SC vision test were compared to visual 
acuity results from DHB eye clinics and optometrist assessments, for all pooled 
data, and for data stratified DHB, gender, ethnicity, geographical location, 
screening result, and diagnosis. Since the optometrist and DHB measurement of 
visual acuity is the ‘gold standard’, the B4SC data was compared to the ‘gold 
standard’ VA data with a two-sided paired t-test. The mean error of the B4SC VA 
results was also plotted against the optometrist/DHB obtained VA, to determine 
whether there is any bias within the distribution of error.  
     Sensitivity and specificity, as well as positive and negative predictive values was 
calculated per DHB and from pooled data. This was done by determining the 
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numbers of true positives, true negatives, false positives, and false negatives of the 
B4SC screening, in children seen at a DHB eye clinic, optometrist, or private 
ophthalmologist. Using published rates of amblyopia and refractive errors in 
comparable populations, the total prevalence of amblyopia in the B4SC screened 
population was determined.  
     This allowed an estimation of the number of cases of amblyopia in the group of 
children screened but not seen at a DHB eye clinic, optometrist, or private 
ophthalmologist. Using a best-case scenario (i.e. all undetected cases of amblyopia 
belong to the children with a positive screen but no further follow-up) and a 
worse-case scenario (i.e. all undetected cases of amblyopia belong to children who 
passed the screening and were not seen), we were able to calculate the sensitivity, 
specificity, positive and negative predicative values of the B4SC vision screening, 
for best and worst-case outcomes, giving a range of values in which the true values 
lie.  
     B4SC referral rates and optometrist/DHB diagnoses of amblyopia and 
ophthalmic diagnoses were analysed according to ethnicity, comparing pooled, 
intra- and inter-DHB means descriptively and using Pearson’s chi-squared test 
where ethnicity index category sample sizes permitted. 
 
5.7   Ethics and informed consent 
 
     Institutional review board approval for this study was obtained from the 
University of Otago (Health) Research Ethics Committee. Specific informed consent 
for participation in this study was not required to be obtained from children’s 




Chapter Six - Results 
6.1   The Study Population 
 
     This study identified and collected demographic data (name, date of birth, and 
NHI) for 958 children aged between 4 and 7 years who were seen at Southern and 
Tairawhiti DHB eye clinics between 1 April and 30 November 2016 and 
community optometrists between 1 April and 31 October 2016, in both the 
Southern and Tairawhti DHB catchment areas. This comprised 744 children from 
SDHB region (396 seen at SDHB, 348 seen at SDHB region optometrists) and 214 
children from the TDHB region (22 seen at TDHB, 192 seen at TDHB region 
optometrist).  
     There was a total of 99 of these children who also underwent vision screening 
as part of the B4SC between 1 April and 30 September, and thus eligible for 
inclusion in this study (53 in SDHB, 46 in TDHB). In the SDHB, 22 children were 
seen at an optometrist as well as screened for vision by the B4SC, and 31 children 
were seen at the DHB eye clinic as well as screened. In the TDHB, 46 children were 
seen at an optometrist as well as screened for vision by the B4SC, 1 of whom was 
also seen at the DHB eye clinic.  The numbers of children identified through 
optometrists and DHB eye clinics, the numbers of children screened by the B4SC, 
and the numbers of children receiving both, in the SDHB, TDHB, and combined, are 
















Figure 8: Numbers of Children Seen at Optometrists, DHB eye clinics, and B4SC in both SDHB and TDHB 
 
6.2   Collection of Data 
6.2.1   Optometry Data 
 
     Optometry practices in the SDHB and TDHB areas were identified and asked to 
participate by noting clinical records of the relevant children seen at the practice. 
In the SDHB, 21 optometry practices were identified and approached, all of which 
initially agreed to participate. The practices were in Dunedin, Invercargill, 
Queenstown, Wanaka, Oamaru, and Te Anau. Complete records were obtained 
from 17 practices in the SDHB, partial records between June and October 2016 
were obtained from 1 practice due to software issues, and 3 practices were not 
able to supply data. The relative numbers of children aged 4-7, who were also 
screened for vision by the B4SC, seen at the practices that did supply their clinical 
records are shown (fig. 9). 
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     Three of the practices in SDHB offer a free optometry assessment for children. 
The bars in blue represent practices that see children for free for the child’s first 
visit. The red bar represents the practice from which partial records were 
obtained, which also happened to offer free assessment to children.  
 
Figure 9: Number of Children in Study Seen at Different Optometry Practices in SDHB 
 
 
     In TDHB, three optometry practices were identified and approached, all of 
which agreed to participate and supplied complete records; all were in Gisborne. 
The relative numbers of children aged 4-7 seen at these practices, who were also 
screened for vision by the B4SC are shown (fig. 10). One practice offers free 















Figure 10: Numbers of Children Seen at Different Optometry Practices in TDHB 
 
6.2.2   DHB Data 
 
     Data from DHB eye clinics was obtained by identifying relevant children from 
patient management software and collecting from their clinical records. The 
Southern DHB provides eye clinics in Dunedin Hospital (Dunedin) and Southland 
Hospital (Invercargill). Dunedin Hospital reviews children referred from the B4SC 
within four months of referral, usually by an orthoptist. Southland Hospital Eye 
Department does not take referrals directly from the B4SC, as they are required to 
be reviewed by a community optometrist first for their referral to be accepted. 
There were 31 children in the study who were seen at a SDHB DHB eye clinic, all of 
whom were seen at Dunedin Public, none at Southland Hospital.  
     In TDHB, the DHB eye clinic is located at Gisborne Hospital (Gisborne). Gisborne 
Hospital eye department also does not take referrals directly from the B4SC. There 
was one child in the study seen at the TDHB eye clinic, who was also seen in the 













Different TDHB Optometry Practices
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6.3   B4 School Check Outcomes 
 
     The numbers of children who were eligible for and were screened for vision by 
the B4SC between 1 April and 30 September 2016, and the numbers of those 
children who were also seen at a local optometrist between 1 April and 31 October 
2016 or at a DHB Eye Clinic between 1 April and 30 November 2016, at the SDHB, 
TDHB, and combined, respectively, are shown below (tables 4-6).  
 Number of Children (%) 
Eligible for Screening 1942 (100) 
Under Care of Eye Health Professional at time of 
Screening (thus not screened) 
54 (2.8) 
Received Screening and not Already Under Care
  
1739 (92.1) 
Failed Vision Screening  134 (7.7) 
Failed and seen at optometrist or DHB eye clinic  43 (32.1) 




Passed and seen at optometrist or DHB eye 
clinic  
10 (0.6) 
Table 4: Number of children in the SDHB eligible for B4SC Vision Screening and the main outcomes of this screening 
 Number of Children (%) 
Eligible for Screening 402 (100) 
Under Care of Eye Health Professional at time of 




Received Screening and not Already Under Care
  
370 (98.4) 
Failed Vision Screening  42 (11.4) 
Failed and seen at optometrist or DHB eye clinic  31 (73.8) 
Failed and not seen at optometrist or DHB eye 
clinic 
11 (26.2)  
Passed and seen at optometrist or DHB eye 
clinic  
15 (4.6) 
Table 5: Number of children in the TDHB eligible for B4SC Vision Screening and the main outcomes of this screening 
 
 Number of Children (%)  
Eligible for Screening 2344 (100) 
Under Care of Eye Health Professional at time of 
Screening (thus not screened) 
80 (3.4) 
Received Screening and not Already Under Care
  
2109 (93.1) 
Failed Vision Screening  176 (8.3) 
Failed and seen at optometrist or DHB eye clinic  74 (42.0) 
Failed and not seen at optometrist or DHB eye 
clinic 
102 (58.0) 
Passed and seen at optometrist or DHB eye 
clinic  
25 (1.3) 
Table 6: Number of children in both the SDHB and TDHB eligible for B4SC Vision Screening and the outcomes of this 
screening 
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     11.4% of children failed vision screening in TDHB, compared to 7.7% in SDHB. A 
two-sided χ2 test between failing vision screening in the SDHB and TDHB had a p-
value of less than 0.0213, suggesting that there is a statistically significant 
difference between the numbers of children failing the vision screening for these 
two groups.  
     Of the children who failed the vision screening, 67.9% were not seen by an 
optometrist or DHB eye clinic in the SDHB, compared to 26.2% in TDHB. A two-
sided χ2 test for failing and not being seen versus failing and being seen, comparing 
the SDHB and TDHB had a p-value of less than 0.00002, suggesting that there is a 
statistically significant difference between the numbers of children failing the 
vision screening and not being reviewed by an optometrist or DHB in the study 
period for these two groups. 
 
 
6.4   Ethnicity 
 
     The ethnicity distribution for all children screened was recorded at each B4 
School Check visit. The numbers of different ethnicities in children from the SDHB, 
TDHB, and combined, who were eligible for this study, who failed their B4SC vision 
screen, and who were found to have a VA of 6/9 or worse in either eye are outlined 
below (tables 7-9).  
















found to have 
reduced VA 
(%) 
NZ European 1148 (66) 34 (64) 88 (66) 13 (54) 
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NZ Maori 313 (18) 10 (19) 28 (21) 5 (21)  
Asian 107 (6) 4 (7) 10 (7) 2 (8) 
Pacific 
Islander 
73 (4) 2 (6) 6 (4) 2 (8) 
Other 98 (6) 3 (4) 2 (2) 2 (8) 
Table 7: Ethnicity Distributions in SDHB 
















found to have 
reduced VA 
(%) 
NZ European 109 (30) 13 (30) 9 (22) 4 (18) 
NZ Maori 238 (64) 27 (61) 32 (76) 18 (78) 
Asian 11 (3) 2 (5) 0 (0) 0 (0) 
Pacific 
Islander 
9 (2) 1 (2) 0 (0) 0 (0) 
Other 3 (1) 1 (2) 1 (2) 1 (4) 
Table 8: Ethnicity Distributions in TDHB 
















found to have 
reduced VA 
(%) 
NZ European 1257 (60) 47 (48) 97 (55) 17 (36) 
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NZ Maori 551 (26) 37 (38) 60 (34) 23 (49)  
Asian 118 (6) 6 (6) 10 (6) 2 (4) 
Pacific 
Islander 
82 (4) 3 (3) 6 (3) 2 (4) 
Other 101 (5) 4 (4) 3 (2) 3 (6) 
Table 9: Ethnicity Distributions in SDHB and TDHB 
 
 
6.4.1   Ethnicity Comparison of all Children Included in the Study 
      
     The following graphs show the proportion of children within different 
ethnicities who met the study criteria in both the SDHB and TDHB. (figs. 11,12)  
 
















Figure 12: Ethnicity Distribution of Children in Study in TDHB 
 
In the SDHB 64% of children who were included in the study were New Zealand 
European, and 19% were Maori. However, in the TDHB 30% of the children were 
New Zealand European, and 61% were Maori. A two-sided χ2 test assessing 
differences in the frequencies of NZ Maori versus non-Maori children in the study 
between SDHB and TDHB had a chi-square statistic of 36.75, and a p-value < 
0.000001, and so there is a statistically significant difference in the proportion of 
Maori to non-Maori between the SDHB and TDHB.  
 
6.4.2   Ethnicity Comparison of all Children Screened for Vision and who 
Failed 
     The percentages of different ethnicities of all children who failed their B4SC 













Figure 13: Ethnicity Distribution of all Children Who Underwent Vision Screening and Failed, in SDHB 
 
 
Figure 14: Ethnicity Distribution of all Children Who Underwent Vision Screening and Failed, in TDHB 
 
     A two-sided χ2 test assessing differences in ethnicity frequencies between all 






















failed vision screening in SDHB had a p-value of <0.294, which means there is no 
statistically significant difference between these.  
     A two-sided χ2 test assessing differences in ethnicity frequencies between all 
children who were screened for vision in the population and children who had 
failed vision screening in TDHB had a p-value of <0.727, which means there is no 
statistically significant difference between these.  
 
 
6.4.3   Ethnicity Comparison of all Children Included in Study Found to Have 
Reduced Vision 
      
     The percentages of different ethnicities in children who were found to have 
reduced VA in either eye (6/9 or worse), upon testing at an optometrist or DHB 
clinic, in both the SDHB and TDHB, are shown below (figs. 15,16). 
 















Figure 16: Ethnicity Distribtuion of Children with Reduced Vision (6/9 or worse) in TDHB 
 
A two-sided χ2 test assessing differences in ethnicity frequencies between all 
children who were screening for vision in the population and children who had a 
VA of 6/9 or worse in either eye in SDHB had a p-value of <0.647, which means 
there is no statistically significant difference between these.  
A two-sided χ2 test assessing differences in ethnicity frequencies between all 
children who were screening for vision in the population and children who had a 
VA of 6/9 or worse in either eye in TDHB had a p-value of <0.360, which means 
there is also no statistically significant difference between these.  
 
6.5   Socioeconomic Differences Between Southern and Tairawhiti DHBs 
 
     The proportions of the populations of SDHB and TDHB in deprivation quintiles, 
five groups each representing 20% of the population ordered by socioeconomic 
status, were obtained from census data from the Ministry of Health.(151) The 












deprived and quintile 5 the least, for both the SDHB and TDHB, are demonstrated 
in figure 13.  
 
 
Figure 17: Percentages of SDHB and TDHB Populations in each SES Quintile 
 
     This shows that the SDHB population is underrepresented in higher deprivation 
levels (quintiles Q1, Q2, Q3) and overrepresented at lower deprivation levels 
(quintile Q5). There is a Pearson correlation coefficient of 0.853 for the proportion 
of SDHB population against the deprivation quintile, suggesting that there is a 
strong positive relationship between SDHB population and the SES quintile. The 
TDHB population appears underrepresented at the highest SES quintile (Q5), and 
overrepresented at the lower SES quintiles (Q1 and Q2). There is a Pearson 
correlation coefficient of -0.866 for the proportion of TDHB population against the 
deprivation quintile, suggesting that there is a strong negative relationship 
between SDHB population and the SES quintiles 
     Socioeconomic stratification or standardisation for children in this study is not 

























Each quintile of New Zealand SES
Percentages of SDHB and TDHB Populatios in 
each SES Quintile
SDHB TDHB Linear (SDHB) Linear (TDHB)
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6.6   Visual Acuity Comparison 
 
     VA data collected from the B4SC Vision Screening was compared to the VA data 
collected from the first assessment at the optometrist or DHB appointment, for 
each eye. There were 18 children in the study group where VA was not recorded 
by the B4SC, or did not undergo VA testing at an optometrist or DHB eye clinic 
assessment. Frequencies of these VA recordings, for the B4SC and follow-up 
assessment, are recorded below (fig. 18,19) 
 
 

































Visual Acuity (snellen fraction)
Frequencies of Unilateral VA Levels Determined 




Figure 19: Frequencies of Unilateral VA levels determined by Optometrists or DHB Eye Clinics 
     The VA results obtained from the B4SC and the optometrist or DHB were 
converted to logMAR units, and the means and standard deviations were 
calculated for each, and compared with a two-sided paired t-test for each eye of the 
81 children. It must be noted that the method of VA testing differs among eye 
health care professionals at DHB and optometry practices, while the B4SC testing 
protocol dictates Parr letter matching is performed on all children. The testing 
methods used at DHB and optometry practices, and frequency thereof are listed 
below (table 10): 
VA testing methods Frequency 
Snellen Chart 46 
Lea Symbols 14 
Crowded Kay Pictures 18 
Parr Letter Matching 1 
Other 2 

































Visual Acuity (snellen fraction)
Frequencies of Unilateral VA Levels Determined by 
Optometrist or DHB Eye Clinic
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B4 School Check VA  Optometrist and DHB Eye 
Clinic VA 
Paired t-test 
0.215 (~6/10) ± 
0.184 
0.189 (~6/9) ± 0.207 
 
t = -2.02           p < 
0.045 
Table 11: Mean ± standard deviation of VA results from B4SC and optometrist/DHB, and paired t-test 
      
     As the p value from the two-sided paired t-test is less than 0.05, at a confidence 
of 95% there is some statistical difference between the VA results from the B4SC 
and VA results from optometrists and DHB eye clinics.  Thus, the B4SC data 
underestimated the child’s ‘gold standard’ VA, which is appropriate for a screening 
test, to minimise false negatives. There is a correlation between the VA results 
from the screening and the VA from optometrists/DHB eye clinic. Pearson’s 
correlation coefficient was 0.655, which suggests that a worse VA in screening 




6.7   The ‘Error’ of Visual Acuity Screening 
 
     It can be assumed that the VA measurements detected by optometrists and DHB 
eye clinics are the ‘true’ VA. The difference between the ‘true’ VA and the VA from 
screening is the ‘error’ of each VA measurement. This can be plotted against the 
‘true’ VA, to examine the effect that a child’s vision has on the amount of difference 





Figure 20: Scatter graph comparing True VA versus Screening VA ‘error’ 
 
     Visually, this shows that at mild to moderate VA deficits, the error of VA from 
screening is well spread around the mean of the ‘error’, suggesting that screening 
is as likely overestimate as well as underestimate the VA at these levels. However, 
at more severe ‘true’ visual acuities, about 0.6 logMAR and worse, most of the error 
tends to be positive, suggesting that screening children with very low vision is 
likely to underestimate the degree of VA deficit.  The Pearson correlation 
coefficient for this comparison is 0.514, suggesting that there is a correlation 
between having a worse VA, and having an increased amount of ‘error’ in VA 
screening in one direction.  
6.8   Ocular Abnormalities in the Study Population 
 
     Any cause of reduced VA, defined as a VA of 6/9 or worse in either eye, or other 
eye pathology, as determined by optometrist and DHB eye clinic assessment were 
recorded.  The numbers for each cause of reduced VA, or vision abnormality 
identified by an optometrist or DHB eye clinic for SHDB, TDHB, and collectively, 























'True' VA as determined by optometrist and DHB eye clinic assessment
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Number of Screened Children Seen by 
an Optometrist or DHB eye clinic in 
SDHB 
53 
Number of confirmed reduced VA 24 









(+2.50D or worse) 
7 
Astigmatism (1.50 
D or worse) 
11 




(Difference of 1.0 
D for 
hypermetropic, 2.0 
D for myopic, and 




Strabimus 2 (2 exotropia) 
Other 0 




Number of Screened Children Seen by 
Optometrist or DHB eye clinic in TDHB 
46 
Number of confirmed reduced VA 23 





Refractive Error  Total 22 
Hypermetropia 
(+2.50D or worse) 
5 
Astigmatism (1.50 
D or worse) 
12 




(Difference of 1.0 
D for 
hypermetropic, 
2.0 D for myopic, 




Strabismus 1 (1 exotropia) 
Other 0 





Number of Screened Children Seen by 
an Optometrist or DHB eye clinic in 
SDHB 
99 
Number of confirmed reduced VA 47 









(+2.50D or worse) 
12 
Astigmatism (1.50 
D or worse) 
23 




(Difference of 1.0 
D for 
hypermetropic, 2.0 
D for myopic, and 




Strabimus 3 (3 exotropia) 
Other 0 




6.9   Cycloplegic Refraction of Children in Study Population 
 
     The mean and 95% confidence intervals for the spherical equivalent of 
cycloplegic refraction data in for children with normal vision, hypermetropia, and 
myopia, and anisometropia (in differences between each eye) for the SDHB, TDHB, 
and combined, as well as mean and 95% confidence interval of the cylindrical 
power for astigmatism for each DHB, are shown below (tables 15, 16).  
 




95% Confidence Interval 
(D) 
Normal (29) +0.55 +0.39, +0.70 
Hypermetropia (7) +4.00 +3.30, +4.70 
Astigmatism (11) 1.72 0.73, 2.71 
Myopia (2) -1.88 -2.02, -1.74 
Anisometropia (4) +3.54 +1.95, +5.53 
Table 15: Mean and 95% Confidence Intervals for Cycloplegic Refraction in SDHB 
 




95% Confidence Interval 
(D) 
Normal (24) +0.49 +0.35, +0.63 
Hypermetropia (5) +3.24 +2.66, +3.82 
Astigmatism (12) 1.45 1.19, 1.71 
Myopia (2) -2.13 -2.54, -1.71 
Anisometropia (3) +2.88 +0.88, +6.02 
Table 16: Mean and 95% Confidence Intervals for Cycloplegic Refraction in TDHB 
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6.10   Management of Children in Study Population 
 
     Possible management for children seen by an optometrist included 
discharge/review later, glasses, occlusion therapy, or ophthalmology referral, and 
possible management for children seen at a DHB eye clinic included discharge, 
glasses, occlusion therapy, or surgery. The number of children receiving various 
treatments from optometrists and DHB eye clinics are shown below (tables 17-20).   
Number of Cases Type of Management 
Seen by Optometrist: 22    
No ocular issue or pathology: 15 Review Later: 15 
Refractive Error: 6 Glasses: 5 
Review Later: 1 
Amblyopia: 1  Glasses: 1  
Patching: 0  
Strabismus: 1 Refer to DHB Ophthalmology: 1 
Table 17: Management of Children Seen by an Optometrist in the SDHB 
Number of Cases Type of Management 
Seen by DHB Eye Clinic: 31    
No ocular issue or pathology: 12  Discharge: 12  
Refractive Error: 18 Glasses: 15 
Review Later: 3 
Amblyopia: 3 Glasses: 3 
Patching: 2  
Strabismus: 1 Active Review: 1 




Number of Cases Type of Management 
Seen by Optometrist: 46  
No ocular issue or pathology: 22 Review Later: 22 
Refractive Error: 23 Glasses: 21 
Review Later: 2 
Amblyopia: 3 Glasses: 2 
Patching: 1 
Refer to Ophthalmology: 1 
Strabismus: 1 Refer to DHB Ophthalmology: 1 
Table 19: Management of Children Seen by an Optometrist in the TDHB 
 
Number of Cases Type of Management 
Seen by DHB Eye Clinic or Optometrist: 
46 
 
No ocular issue or pathology: 22 Review Later: 22 
Refractive Error: 23 Glasses: 21 
Review Later: 2 
Amblyopia: 3 Glasses: 2 
Patching: 1 
Refer to Ophthalmology: 1 
Strabismus: 1 Refer to DHB Ophthalmology: 1 




6.11   False Positive, False Negative, True Positive, and True Negative 
Outcomes 
 
     99 children who were screened for vision within the study period were seen at 
an optometrist or DHB Eye clinic. Of these, 74 had failed the vision screening, and 
25 had passed. Tables 21-23 show the numbers of true positive (where ‘gold 
standard’ VA testing at screening would have resulted in failure), false positive 
(where ‘gold standard’ VA testing at screening would have resulted in passing), 
true negative (where ‘gold standard’ VA testing at screening would have resulted 
in passing), and false negative (where ‘gold standard’ VA testing at screening 
would have resulted in failure) referrals from the B4SC Vision Screening for 
children seen at an optometrist or DHB eye clinic, as determined by the post-
screening follow-up appointment, for the SDHB, TDHB, and combined, 
respectively.  
Screening Result Follow-up Result 
Failed: 43 True Positive: 23 
 False Positive: 20 
Passed: 10 True Negative: 9 
 False Negative: 1 
Table 21: Screening outcomes and follow-up results for the SDHB 
Screening Result Follow-up Result 
Failed: 31 True Positive: 19 
 False Positive:  12 
Passed: 15 True Negative: 11 
 False Negative: 4 




Screening Result Follow-up Result 
Failed: 74 True Positive: 42 
 False Positive: 32 
Passed: 25 True Negative: 20 
 False Negative: 5 
Table 23: Screening outcomes and follow-up results for the SDHB and TDHB 
 
 
6.12   Positive Predictive Value 
 
     The positive predictive value is equal to the proportion of those cases which fail 
the screening who do have a true VA of 6/9 or worse in either eye. Calculation of 
this assumes there was no factor other than failing the B4SC vision screening 
programme influencing the likelihood of presentation at an optometrist or DHB 
eye clinic within the study period.  
The PPV of the B4SC vision screening programme in SDHB = 53.5% 
The PPV of the B4SC vision screening programme in TDHB =61.3% 
The PPV of the B4SC vision screening programme in both the SDHB and TDHB = 
56.8% 
 
NPV cannot be calculated as the study design did not allow for representative data 




6.13   Estimation of Sensitivity, Specificity, and Negative Predicative Value 
 
     This study was a retrospective audit, and only looked at the data for children 
who had been screened as well as being seen by an optometrist or DHB eye clinic 
within the study period. Therefore, no data other than what was collected at the 
time of vision screening was gathered for children who were not seen at an 
optometrist of DHB eye clinic, regardless of their vision screening outcome. This 
unfortunately means that determination of the true sensitivity, specificity, and NPV 
is not possible. However, it is possible to calculate a range of possible values for 
these, by estimating the vision status of the children who were screened, 
regardless of screening outcome, who were not seen by an optometrist of DHB eye 
clinic within the study period. 
     One can estimate the prevalence of conditions that would cause a VA loss in 
children at four years, which would be significant enough to not pass the B4SC 
vision screening, by using data from analogous studies and populations. The main 
diseases affecting the vision status of a four-year-old are amblyopia and/or 
refractive error. One can calculate a window of possible outcomes for the 
measures of screening accuracy by using two assumptions: the best case, which 
assumes the unseen children would have the maximum number of allowed true 
positives and true negatives, and the worst-case, which assumes the unseen 
children would have the maximum allowed number of false positives and false 
negatives.   
     The prevalence of amblyopia/and or refractive error that causes a reduction in 
VA to at least 6/9 in either eye in NZ has been found to be 5.45%(98), and so the 
number of expected number of cases of reduced VA in this study population is 
approximately 119 children. As there were 47 cases of confirmed reduction in VA, 
it can be assumed there around about 72 cases of reduced VA in the population 
who received screening, but did not present to an optometrist or DHB eye clinic 
during the study period.  
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     Table 24 shows the best case for the vision screening:  that after accounting for 
known total expected number of positives (119) and the total number of positive 
screening results (176), the maximum number of positive cases were screened as 
positive, and the maximum number of negative cases were screened as negative.  
 
  Screening 
Outcome 
  
  Positive Negative  
True Result Positive  TP: 114 FN: 5 119 
 Negative FP: 62 TN: 2008 2070 
  176 2013 2189 
Table 24: Best-case scenario for B4SC Vision Screening outcomes in SDHB and TDHB 
 
Best-case Sensitivity = 95.8% 
Best-case Specificity = 97.0% 
Best-case NPV = 99.9% 
 
     Table 25 shows the worst case for the vision screening:  that after accounting for 
known total expected number of positives (119) and the total number of positive 
screening results (176), the maximum number of positive cases were screened as 






  Screening 
Outcome 
  
  Positive Negative  
True Result Positive  TP: 42 FN: 77 119 
 Negative FP: 134 TN: 1936 2070 
  176 2013 2189 
Table 25: Worst-case scenario for B4SC Vision Screening outcomes in SDHB and TDHB 
 
 
Worst-case Sensitivity = 35.3% 
Worst-case Specificity = 93.5% 




Chapter Seven - Discussion 
 
7.1   Main Findings 
 
7.1.1   How Well the B4SC Vision Screening Programme is working 
 
     The primary aim of this study was to evaluate how well the B4 School Check 
vision screening programme in New Zealand is performing its function, by 
examining the vision screening results, and comparing these to data from 
optometrist and DHB eye clinic assessments for children who have been screened 
for vision, in two geographically, ethnically, and economically distinct District 
Health Boards. If there is to be a public investment into a population vision 
screening programme, it should be able to detect as many children with a vision 
problem as possible, meaning it should reach the highest number of eligible 
children it can, and have the most accurate screening results: not passing excess 
children who do have visual deficits nor failing children with normal vision.  
 
7.1.2   Coverage 
 
     Screening programmes should be able to reach the majority of the target 
population, to maximise the number of cases that are detected so there are no 
cases left untreated. In the SDHB, the number of children identified as eligible for 
screening between 1 April and 30 September 2016 was 1888, 1739 (92.1%) of 
whom received screening, excluding those children identified as already under eye 
health care. In the TDHB, the number of children identified as eligible for screening 
within the study period was 376, 370 (98.4%) of whom received screening, 
excluding those children identified as already under eye health care. Overall, there 
were 2109 children screened for vision by the B4SC within the study period, 
93.1% of the total 2264 eligible. These are high percentages of children in the 
population who do receive screening, which is indicative that the B4 School Check 
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is effective at providing vision screening to a large proportion of eligible children. 
However, this is not as high as has been reported in other health systems, for 
example, in Sweden, where vision screening in 4 year olds has an uptake of over 
99% of the population, suggesting there is still capacity for improvement in the 
reach of the B4SC.(169) Possible reasons for coverage of the B4SC not reaching 
100% of the population may be due to parents declining childhood vision 
screening, which may indicate a lack of knowledge regarding the importance of 
vision screening, or perhaps there is some difficulty in VHTs arranging vision 
screening, and either there being not enough VHTs to meet the screening need, or 
regional challenges that occur with sizable populations in New Zealand living 
rurally and are difficult for VHTs to meet, for example.  However, New Zealand 
vision screening coverage does do well compared to some populations: uptake of 
vision screening has been found to be as low as 51% nationally in Iran(170), and 
45% in Alberta, Canada.(171) 
     One issue with implementation of vision screening programmes is the timing of 
screening. There must be a balance where screening occurs early enough in a 
child’s visual development so that prevention and treatment of amblyopia and its 
risk factors is possible and optimised, and not too early that children who do 
eventually develop amblyopia are missed. The B4SC aims to screen children’s 
vision shortly after their fourth birthday. However, this can mean by this time a 
significant proportion of children with visual and ocular defects may have already 
presented to eye health care providers, making vision screening of these children 
redundant. The numbers of children identified for vision screening and already 
under care of an eye health care provider between 1 April and 30 September 2016 
in the SDHB was 54 (2.8%), and in the TDHB 26 (6.5%). This is not an insignificant 
number, especially when compared to the numbers of children who are failing 
vision screening (134 and 42 in SDHB and TDHB, respectively). This suggests that 
screening may be occurring too late, as children are already presenting to eye 
health care providers regardless of screening. However, it was not investigated 
what the reason for these presentations were, nor how the children came to 
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present, i.e. through parental concern or issues detected in other child health 
checks.  
     One way to analyse whether children with vision problems are being detected 
too late is to examine long-term vision screening outcomes. Currently, no data 
exists for the long-term outcomes of the B4SC vision screening, and whether it 
prevents amblyopia. However, a long term study in Sweden of vision screening of 
four-year-olds found that the prevalence of amblyopia decreased from 2% to 0.2% 
from 1970 to 1992, which demonstrate that screening does reduce 
prevalence.(162)  
 
7.1.3   Accuracy of Vision Screening 
 
     As well as screening the maximum number of children it can, a vision screening 
programme also ought to be as accurate as possible. The B4SC vision screening 
programme uses a VA level of 6/9 in one eye, or 6/12 in either or both eyes for the 
threshold for referral, i.e. a screening fail. Almost all first vision assessments at an 
optometrist or DHB eye clinic for children includes measuring the uncorrected 
visual acuity of each eye, and because these measurements are likely to guide 
further treatment and be more indicative of a child’s true VA, these VA 
measurements were taken as the true levels or “gold standard’. Thus, for each child 
referred from the B4SC and seen by an optometrist or DHB eye clinic in the study 
period, VA data was available from the screening programme, and the clinical 
assessment.  
     Our study found relatively small numbers of children who had failed vision 
screening and had been assessed at an optometrist or DHB eye clinic (43 and 31 
for SDHB and TDHB respectively). Of these, approximately half were found to have 
a truly reduced VA (23 and 19 for SDHB and TDHB respectively). Of those children 
who passed vision screening but had still been assessed at an optometrist or DHB 
eye clinic during out study period (10 and 15 for SDHB and TDHB respectively), 
91 
 
only a small minority were found to have abnormal VA (1 and 4 for SDHB and 
TDHB respectively).  
 
7.1.4   Positive Predictive Value 
 
     The positive predictive value, which is the proportion of cases who fail the 
screening who do have true VA that would lead to a fail of a vision screen, of the 
B4SC vision screening programme in SDHB was 53.5%, in TDHB 61.3%, and 
collectively 56.8%. This means that only slightly over half the cases of children 
screened for vision and who fail, do truly have a visual deficit. The implication for 
this is that a significant number of children are being referred for further 
assessment, when they have no visual problems, which can lead to worry for 
parents and the child, economic cost to the parents for initial assessment at an 
optometrist, and unnecessary economic costs and increased demand of limited 
resources on DHBs that assess children referred from the B4SC. A study of the 
B4SC vision screening programme in Counties-Manukau DHB (CMDHB) found a 
PPV of 31%, due to a high number of false positives.(168) This was partially 
explained by the large proportion of children in the CMDHB who did not speak 
English at home, and so were referred on for more detailed visual assessment. 
Thus, DHBs where more children would speak English at home (such as SDHB and 
TDHB) would expect fewer false positives, and thus a higher PPV. Other screening 
programmes have reported comparable PPVs ranging from 35 to 81%, including 
the Rotterdam AMblyopia Screening Effectiveness Study (RAMSES), a seven year 
follow up study, which found a PPV of 42%.(172–175)  
     There are numerous potential causes for such a low PPV in the B4SC childhood 
vision screening. Positive predictive value directly correlates with prevalence. 
Amblyopia is a relatively uncommon condition (prevalence of 1-5%) and so most 
children screened will not have any visual deficit, meaning there is a greater pool 
of visually normal children from which to draw false positives (95-99% of children 
screened), compared to the pool from which to draw true positives. This means 
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that even with relatively high sensitivity and specificity, there can still be a low 
PPV. Children who are screened at four years of age may be uncooperative with 
vision screening, and this may lead to the VHTs wanting to refer these children on, 
without properly measuring the child’s VA. Also, VHTs may prefer to err on the 
side of caution with vision screening and refer children with borderline vision lest 
they have a vision problem that is missed. Another reason for the low PPV may be 
that visual acuity testing itself may be subject to wide degree of variation between 
testers, who are not as highly trained at measuring VA as optometrists or other eye 
health care providers, and variation between testing conditions, such as screening 
occurring in schools, which may have inadequate lighting, other distractions, and 
not measuring VA from the exact distance (4m) for instance. VHTs may also not be 
as thorough with testing compared to optometrists and orthoptists, as they are 
functioning as screeners rather than diagnosticians.   
 
7.1.5   Negative Predictive Value, Sensitivity, and Specificity 
 
     NPV, sensitivity, and specificity of the B4SC vision screening could not be 
directly calculated because the study design did not allow representative data for 
children who passed the vision screening to be collected, meaning that the children 
who were presenting to optometrists or DHB eye clinics having passed the 
screening, were unlikely to have been a representative sample of all children who 
passed the screening. Therefore, these values had to be estimated by determining 
the expected number of cases of reduced VA in the population of four year olds 
screened, with analogous prevalence data, and finding a possible range of values 
using the best-case (the unaccounted numbers of false screening results were 
minimised, and the unaccounted numbers of true screening results were 
maximised), and worst-case (the unaccounted numbers of false screening results 
were maximised, and the unaccounted numbers of true screening results were 
minimised) screening outcomes.  
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     The range of possible NPVs were 96.1% - 99.9%. This means that the true 
probability of a child who passes vision screening of not having a reduction in 
vision is between 96.1 and 99.9%. These are high values and suggest that very few 
children who pass the screening will have a visual problem, meaning there is likely 
to be very few children in the community with unidentified and untreated visual 
deficits. Potential reasons for the high NPV are that children who are near the 
threshold for screening referral are referred anyway, corroborated by the 
relatively low PPV, and so all the children who are passing vision screening are 
passing clearly. Another reason is that in relatively rare conditions, such as 
amblyopia, most instances of passing screening will happen to be true negatives, 
simply because most cases will be negatives.  
     The range of sensitivity values was 35.3% - 95.8%. The sensitivity is the 
proportion of instances of reduced vision (6/9) that would be detected with 
screening. The range of possible sensitivity values is very large, and therefore it is 
difficult to draw any meaningful conclusions from this. However, there have been 
numerous studies examining the sensitivity of various screening programmes, and 
has found sensitivity values to range from 65 to 85%. (176–178) 
     The range of specificity was 93.5% - 97.0%. The specificity is the proportion of 
instances of normal vision that pass vision screening. This is a relatively narrow 
interval, and relatively high, suggesting that most cases of normal vision are not 
being referred by the B4SC.  
 
7.1.6   Visual acuity screening accuracy 
 
     Another way to assess the accuracy of the B4SC vision screening is to look at the 
VA results for each eye of each child, from both the B4SC and that child’s follow up 
assessment at either an optometrist or DHB eye clinic. Two-sided paired t-test 
analysis between VA data the from the B4SC and from optometrist and DHB eye 
clinic assessments gave a p value of less than 0.045, which means there is a 
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statistically significant difference between these two sets of data, at 95% 
confidence.  
     This difference was further explored by analysing the ‘error’ of the B4SC 
screening data. It was assumed that the VA data obtained from optometrists and 
DHB eye clinics was the child’s true VA, and the difference between these values 
and the B4SC VA data values was the ‘error’ of the screening. At lower VA deficits, 
vision better than 6/12, the ‘error’ seems to be evenly distributed as 
overestimating and underestimating the true VA. However, at worse true VA 
deficits, most of the ‘error’ of the vision screening is due to the B4SC 
underestimating the degree of VA deficit. This is probably due to the nature of a 
screening programme, where it does not aim to quantify the precise level of VA 
deficit, rather identify cases that meet the threshold for referral, so they can be 
further investigated by eye health care providers. This means that children with 
severe levels of true VA reduction may not have their extent of VA reduction 
assessed by VHTs, because the child fails the screening, and is referred without 
further testing. This is good because it means extra effort is not used to try to 
precisely quantify the visual deficit of every child during screening, which is an 
efficient use of VHT time.  
     Other reasons for the discrepancy between the VHTs’ VA results and the ‘gold 
standard’ VA results are legion, and include major differences in VA testing method 
between VHTs and eye health care providers, true changes to a child’s vision 
between being screened and appointment with an eye health care professional, 
and screening conditions not always being ideal. If the location where the vision 
screening is occurring is not adequate for testing vision, this may alter the VA 
results, for example, if there was insufficient lighting in the room the screening was 
occurring, this may underestimate the child’s VA. Also, if the screening is occurring 
at a busy preschool or disruptive household, the child’s attention may wane, and 




7.2   Other outcomes from this study 
 
     This study also aimed to describe the causes and nature of amblyopia and 
refractive error, differences in vision screening and amblyopia prevalence between 
SDHB and TDHB, differences in vision screening between different ethnicities, 
attendance at various eye health care providers, and management or amblyopia 
and refractive error.  
7.2.1   Amblyopia and Refractive Error Outcomes 
 
     Of those children identified by out study as having reduced VA (below 6/9) on 
testing at the optometrist or DHB eye clinic (24 and 23 for SDHB and TDHB 
respectively), almost all were cases of refractive error (24 and 22 for SDHB and 
TDHB respectively) – mostly astigmatism (11 and 12 for SDHB and TDHB 
respectively). There were only four cases of amblyopia identified in SDHB patients, 
with three identified in TDHB. Interestingly only three cases of strabismus were  
identified, two in SDHB and one in TDHB, all of which were cases of exotropia.  
 
     The rates of different refractive errors in TDBH and SDHB were recorded. 50% 
of refractive errors were astigmatism, 26% were hypermetropia, 9% were myopia, 
and 15% were anisometropia These proportions of causes of refractive error are 
not too different from the ones found in CMDHB, which found 46% of cases were 
astigmatism, 36% hypermetropia, 3% myopia, and 16% anisometropia.(168)  
     While strabismus in a four-year-old age group is more likely to be esotropia, 
every case identified in this study was exotropia.(83) This suggests that most cases 
of esotropia are not identified in vision screening, or that these children are 
already known to eye health care providers, possibly because of esotropia being 
apparent sooner, and are included in the number of children who were already 
under care at the time of screening. It has been found that the age of onset of 
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accommodative esotropia is three months to seven years, but with a mean age of 




7.2.2   Management of Amblyopia and Refractive Error 
 
     The management of children who were both screened and presented to an 
optometrist or DHB eye clinic was recorded. All children who were identified as 
not having a reduced VA or any eye pathology were not treated, and either 
discharged or often discharged with a plan to be reviewed again at a later data 
(which occurred at most optometry practices). All children identified as having 
refractive error (as per the level used for the definitions in this study) were 
prescribed glasses.  
     Of the 7 children who were diagnosed with amblyopia, three received glasses 
only and three received both glasses and patching. One patient with strabismic 
amblyopia was referred to an ophthalmologist. There are no set clinical guidelines 
for the management of amblyopia in New Zealand, and treatment often depends on 
clinician preferences. However, most cases of anisometropic amblyopia can be 
effectively treated with glasses alone.  
     Of the 30 children presenting to optometrists who were found to have a visual 
problem, only 1 was referred to an ophthalmologist for follow up assessment, 
which was for exotropic strabismus and amblyopia. This suggests that the majority 
of paediatric patients at optometry clinics are not referred, and most cases of 
refractive error and amblyopia are treated by optometrists. One case of strabismus 




7.2.3   Southern DHB versus Tairawhiti DHB 
 
     There are significant differences between the Southern and Tairawhiti DHBs, 
particularly regarding size, population number, ethnicity distribution, and 
socioeconomic status, and thus a study investigating the B4SC in two significantly 
different DHBs allowed a measure of how well vision screening was working in 
two different populations. This means that any differences in screening and vision 
outcomes between SDHB and TDHB may be possibly partially due to these 
differences in the ethnic make-up of each DHB, SES differences between the DHBs, 
and differences in the sizes and geography of the DHBs.  
     There are statistically significant differences in the ethnic proportions between 
SDHB and TDHB. In the SDHB 66% of children screened by the B4SC were NZ 
European, and 18% NZ Maori, compared to TDHB, where 30% of the children 
screened were NZ European, and 64% NZ Maori. There are also significant 
socioeconomic differences between these two regions, with SDHB being 
underrepresented for deprivation, and TDHB overrepresented for deprivation. 
SDHB also has a far larger catchment area, in terms of geography and population.  
     There was a statistically significant difference in the failure rate of screening 
between the SDHB and TDHB, of 7.7% compared to 11.4%. This may be 
attributable to true differences in the vision states between these populations, or 
differences in the screening itself. However, of the children being seen by 
optometrists and DHB eye clinics, 55% did truly have a vision problem in SDHB, 
compared to 50% in TDHB. This difference in vision between children from each 
region was not statistically significant, suggesting that the children in TDHB may 
be more likely to fail vision screening, regardless of their true vision status, which 
could suggest may be a systematic difference in the process of screening between 
the two regions, despite identical guidelines.  
     There was also a statistically significant difference between the quantity of data 
collected between the SHBD and TDHB, with 67.9% of children who failed vision 
screening in SDHB not being identified at either optometrist or DHB eye clinic, 
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compared to 26.2% in TDHB who did not present. This difference may be due to 
several reasons. There are no children in TDHB who are referred directly to the 
DHB eye clinic in Gisborne Hospital, and all referrals must be through a community 
optometrist. Data was collected from all three optometry practices in TDHB, which 
means there is a high probability that all children who would present in the study 
period were identified. However, as over one quarter of children who failed were 
not seen by an optometrist, this suggests there is a large proportion of children 
who fail vision screening who do not present at all. One practice in TDHB assessed 
almost all the children seen by optometrists and the B4SC, and this practice did 
offer free assessment for children. 
     In the SHDB, there was a high number of children failing vision screening were 
not identified at an optometrist or DHB eye clinic, and possible reasons for this 
include missing data from four optometry practices: three practices did not supply 
any data for children they had seen within the study period, and a busy practice in 
the SDHB was not able to supply data that was collected over three months of the 
study period, due to unavoidable software issues. Also, as much of the data 
collection from optometrists depended on the optometrists identifying children in 
the relevant age group as they were seen continuously for seven months, and 
practice software often excluded retroactive searching of patients who were seen 
at specific dates, it is possible that many optometry practices missed some children 
who would have been eligible for the study, simply due to forgetting to record 
identifying parameters for children seen, and multiple optometrists working at 
single practices making it difficult to have 100% of children seen identified within 
each practice.  
     In the SDHB, vision assessment at the Dunedin Hospital is free, and so this may 
be where VHTs may suggest to parents of children who fail vision screening to go. 
However, unlike at an optometry practice, there is a significant waiting time to be 
assessed at the DHB eye clinic (which is limited to four months as per Ministry of 
Health guidelines). Therefore, if many parents prefer their child to be seen at a 
DHB eye clinic, where children may not receive an appointment until four months 
later (perhaps even later if there is delay for the parent to arrange the 
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appointment) the delay in receiving their appointment may have led to some 
children’s clinical assessments not being identified by our study. The data 
collection for DHB eye clinic data extended until the 30 November (two months 
after the B4SC vision screening study period) to attempt to account for these 
differences but may not have been sufficient to catch all children presenting from 
B4SC referral – a four-month extension of the DHB data collection window was not 
possible owing to time limitation of the author’s programme of study.  
     It is nonetheless concerning that 68% of children failing B4SC vision screening 
in the SDHB between April and September 2016, had not been seen by optometrist 
or DHB eye clinic by the end of October 2016 and November 2016, respectively. 
 
7.2.4   Ethnicity and Vision Screening 
 
     Currently, there is little New Zealand data on differences in amblyopia 
prevalences between various ethnic groups. One study published in 1970 did 
describe the differences in refractive error prevalence between groups, and found 
that NZ Europeans are more likely to have both myopic and hypermetropic 
refractive error than Pacific people.(180) Ethnicity may potentially affect vision 
screening outcomes for children, either via systematic differences between various 
ethnicities in the process of screening, such as language and cultural differences 
affecting the screening outcome, and differences in vision status attributable to 
ethnicity. Ethnicity is routinely recorded by VHTs in the B4SC. The ethnicities used 
in this study included NZ European, NZ Maori, Pacific Islander, Asian, and Other (a 
broad category encompassing children from South American, Middle Eastern, and 
African descent). 
     However, there was no statistical difference found between the number of 
children from each different ethnicity receiving screening and failing screening or 
receiving screening and having a reduced VA in either the SDHB or TDHB. This 
suggests that there is little to no difference in the provision of screening and rates 
of vision abnormalities. However, the CMDHB B4SC study did find that NZ Maori 
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and Pacific Islanders were more likely to decline vision screening, compared to NZ 
Europeans, suggesting an avenue for vision disparities between these groups.(168)  
     Overall, it was found that NZ Maori were over-represented among those with a 
reduced VA (78% of reduced VAs), while only comprising 64% of the children 
screened by the B4SC. However, in the context of no statistically significant 
difference in the proportion of NZ Maori who have a reduced VA compared to the 
total screened when comparing TDHB and SDHB separately, this disproportional 
effect is likely an artefact from the fact that relatively more data was collected from 
TDHB. This meant that while NZ European was the largest group screened overall, 
NZ Maori made up a larger proportion of those children eligible for the study, and 
thus found to have a VA reduction. 
 
7.2.5   Optometrist versus DHB Management 
 
     One of the principles of Screening of Wilson and Junger, is that there must be 
facilities for diagnosis and treatment following screening. Children referred from 
the B4SC have the option of either being seen by a community optometrists, a DHB 
eye clinic, or a private ophthalmologist. In the TDHB, the DHB eye clinic does not 
take referrals directly from the B4SC, and so children are firstly referred to an 
optometrist.  
     In TDHB, one optometry practice accounted for the clear majority of children 
who were eligible for the study, and this practice also offers free first assessment 
for children. The reason so many of the children presented here may be due to the 
parents of these children being encouraged by VHTs, who would be aware that this 
practice is the only source of free eye assessment, or parents seeking out the free 
option. 
     There may be a systematic difference in children who present to optometrists 
versus children presenting to the DHB eye clinic at Dunedin Hospital. The DHB eye 
clinic does not cost the parents, whereas most optometry assessments do. This 
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may mean that children from higher SES families may be seen by optometrists 
more than children from low SES families. Therefore, SES analysis of each children 
receiving vision screening and its follow may be an area of future interest. 
Assessment at Dunedin Hospital eye clinic is easily accessible to only children who 
live in Dunedin, usually, meaning children who live in rural regions in the SDHB 
only really have access to local optometrists, which is not free. This economic cost 
may be a deterrent for some children to have a vision assessment. However, the 
Dunedin Hospital eye clinic has a longer waiting time to be seen than an 
optometrist, and so parents who opt to be seen at Dunedin Hospital, may mean 
there is slight delay in the children receiving treatment.  
     There was only one case of an optometrist referring a child for ophthalmological 
assessment, which was for exotropic strabismus. All cases of refractive error and 
anisometropic amblyopia identified in this study by optometrists were managed 
by the optometrists, and treatment of these conditions falls within the scope of 
practice of optometrists. This suggests that optometrists are managing most cases 
referred to them from the B4SC themselves.  
 
7.3   Methodological Considerations 
 
     The design of this study was a retrospective audit, collecting data on all children 
seen at community optometrists and DHB eye clinics in the SDHB and TDHB, and 
comparing them to data collected from the B4SC at the time of screening. This 
method was chosen because it allowed comparison between the VA data from the 
B4SC and follow up assessment.  
     However, there are several issues with this design. Foremost, this study did not 
allow calculation of the true sensitivity, specificity, and negative predictive value. 
This information would need to have been collected with a different study design, 
in which a random group of children screened by the B4SC were tested for vision, 
regardless of their presentation to an optometrist or DHB eye clinic.  
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     Data collected from community optometrists was voluntary, and depended on 
the optometrists collecting and supplying data for every child between 4 and 7 
years, continually for seven months. This presented some issues, such as three 
practices in the SDHB not supplying any data (out of 21), and one only being able 
to supply data for half of the data collection period. Also, there is a strong 
possibility of practices not supplying the data of every child aged 4 to 7 years who 
presented to the practice, evidenced by the 67.8% and 26.2% of children who 
failed screening, who were not seen by an optometrist or DHB eye clinic in the 
SDHB and TDHB, respectively.  
     The ideal way to measure how well the B4SC is performing would be with a 
randomised control trial comparing long-term vision outcomes of children who do 
receive preschool vision screening to those who do not. However, this is not 
practical to perform, as the it would require follow up for years, and does not have 
clinical equipoise, as vision screening programmes have been shown to reduce the 
prevalence of amblyopia in society. 
     Another study design to assess the B4SC vision screening programme is 
randomly selecting a sample of children who receive screening from the B4SC, 
which is then assessed for VA and any ocular disease. This would allow calculation 
of the true values of sensitivity, specificity, PPV, and NPV. However, this study 
design does present an ethical issue, as it may identify children who have a visual 
deficit who passed the screening, and there may not be capacity to treat these 
children. Therefore, this study utilised retrospective data regarding who were 
already seen at an optometrist or DHB eye clinic, which did allow comparison of 
VA data between screening and follow up, calculation of PPV, estimations of 
sensitivity, specificity, and NPV, and  
     Another limitation of the study design was the time of the screening and follow 
up assessment. The study analysed children who were screened by the B4SC 
between 1 April and 30 September 2016. Follow up data for these children was 
obtained from optometrists, who regarding identifying details of all children seen 
aged 4 to 7 years, between 1 April and 31 October 2016, as well as data from DHB 
eye clinics for all children seen aged 4 to 7 years, between 1 April and 30 
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November 2016. This meant there was a month delay between the end of the B4SC 
screening period, and the end of the optometrist data recording period, and a two-
month delay between the end of the B4SC screening period, and the end of the 
DHB eye clinic recording period. It is possible that this delay was not long enough 
to account for the time taken for a child to be referred from the B4SC and the 
parent to arrange appointment with an eye health care provider.  
     The major shortfall of this audit is the limited data. There were many children 
identified as failing the B4SC vision screening, but not identified as being seen at 
any DHB eye clinic or optometrist within the study period: 58% of children who 
failed vision screening.  This does affect the accuracy of the calculations of the 
sensitivity, specificity, NPV, and PPV, particularly if there is some systematic 
difference in the visual statuses between children failing and being seen, and 
children failing and not being seen. Therefore, any future audit of the B4SC should 
ensure there is thorough follow up of as many cases of screening failure as 
possible.  
 
7.4   Further Research needed 
 
     There have been several different areas for further research identified. This 
includes an alternative study design to precisely calculate NPV, sensitivity, and 
specificity of the B4SC vision screening programme. There is a need for research 
on the long-term outcomes of the B4SC, including measuring the risk difference of 
amblyopia for children who receive vision screening compared to those who do 
not. This can be used to quantify the cost-utility of the B4SC. Future research could 
also stratify screening data by SES, to determine the presence and size the effect of 
SES on vision status. There is also a lack of cross-sectional data on the prevalence 
of both refractive error and amblyopia, which would provide important 
information for health resource planning.  Also, the emerging use of 
photoscreeners in various societies for childhood vision screening presents some 
opportunity for potential improvement in childhood vision screening, with their 
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auxiliary use in screening, and so exploration of the effectiveness of these in a New 
Zealand setting could be explored.  
 
7.5   Key conclusions of this study 
 
     Amblyopia is a non-fatal condition, the functional impact of which is of some 
debate. Therefore, if there is to be a nationwide screening programme for 
amblyopia, it should be as accurate as possible, maximising the number of cases in 
society that are treated, and minimising the number of false referrals. The high 
NPV means that most cases of amblyopia will be identified in screening. The 
relatively low PPV, however, does mean that the vision screening is not performing 
as efficiently as possible, and may be generating extra public health care costs, 
with unnecessary referrals to DHB eye clinics.  
     There are concerningly high rates of not having been seen by optometrist or 
DHB after referral from the B4SC. This may be a true effect, which could be due to 
parents not making follow-up appointment after referral or could have been due to 
the study missing a significant number of children who were seen at optometry 
practices. This could be determined by following up with parents of children who 
were referred as to what was done regarding the child’s referral.  
     There are cost implications of DHB versus optometrist referral, given there is a 
low rate of optometry to ophthalmologist referral. Optometrists are managing 
most cases referred to them from the B4SC themselves, which means there is a 
reduced cost for the DHB in management of these children. However, this may 
imply an under-utilisation of orthoptists, who are highly trained allied health 
professional, and may mean there is opportunity for the improvement in the use of 
orthoptist referral pathways for optometrists in the management of some 
paediatric conditions, including amblyopia.  
     No children were identified in this study to have any ocular pathology, aside 
from refractive error, amblyopia, and strabismus. This could be due to: the 
105 
 
relatively rare instances of other eye pathology, and thus not occurring in any 
children included in this study; other pathologies being identified before vision 
screening by other means such as parents, GPs, or paediatricians detecting these 
pathologies; or due to the B4SC vision screening not being able to detect eye 
disease that may be present but does not affect visual acuity.   
     There were very low rates of medical and surgical management of children 
screened by the B4SC identified as having a reduced VA, which may have been due 
to medical and surgical management not being indicated for most cases of VA 
reduction identified. All cases of refractive error, and most cases of amblyopia 
involved conservative management with glasses. All occlusive therapy for 
amblyopia was with patching as opposed to atropinisation. The management of 
children with strabismus assessed and referred to the DHBs was not followed past 
the end of this study, but it is possible that these cases received medical or surgical 
treatment.  
     Most common childhood strabismus cases have already presented by the age 
when they are screened by the B4SC. This means that the B4SC vision screening 
perhaps occurring too late to be effective in detecting cases of strabismus, 
particularly accommodative esotropia. However, many of these cases are detected 
before vision screening occurs by other means, and vision screening is primarily 
for detecting cases of amblyopia. Therefore, missing numbers of strabismus cases 
is not a major downfall of the B4SC, but undiagnosed cases of strabismus may still 
be at risk of amblyopia development.  
     The VHT VA testing is accurate, and while it does underestimate the extent of a 
VA deficit at large VA deficits, and does have a high false positive rate, it is 






  1.  Petrig B, Julesz B, Kropfl W, Baumgartner G, Anliker M. Development of stereopsis and 
cortical binocularity in human infants: electrophysiological evidence. Science. 1981 Sep 
18;213(4514):1402–5.  
2.  Attebo K, Mitchell P, Cumming R, Smith W, Jolly N, Sparkes R. Prevalence and causes of 
amblyopia in an adult population. Ophthalmology. 1998 Jan;105(1):154–9.  
3.  Chua B, Mitchell P. Consequences of amblyopia on education, occupation, and long 
term vision loss. Br J Ophthalmol. 2004 Sep 1;88(9):1119–21.  
4.  Daw NW. CRitical periods and amblyopia. Arch Ophthalmol. 1998 Apr 1;116(4):502–5.  
5.  Maurice DM. The structure and transparency of the cornea. J Physiol. 1957 Apr 
30;136(2):263–86.  
6.  Fisher RF. The elastic constants of the human lens. J Physiol. 1971 Jan 1;212(1):147–80.  
7.  Fisher RF. The force of contraction of the human ciliary muscle during accommodation. 
J Physiol. 1977 Aug 1;270(1):51–74.  
8.  Jeon S, Lee WK, Lee K, Moon NJ. Diminished ciliary muscle movement on 
accommodation in myopia. Exp Eye Res. 2012 Dec;105:9–14.  
9.  Menapace R, Findl O, Kriechbaum K, Leydolt-Koeppl C. Accommodating intraocular 
lenses: a critical review of present and future concepts. Graefes Arch Clin Exp Ophthalmol. 
2007 Apr 1;245(4):473–89.  
10.  Masland RH. The functional architecture of the retina. Sci Am. 1986 Dec;255(6):102–
11.  
11.  Roorda A, Williams DR. The arrangement of the three cone classes in the living human 
eye. Nature. 1999 Feb 11;397(6719):520–2.  
12.  Brown PK, Wald G. Visual Pigments in Single Rods and Cones of the Human Retina. 
Science. 1964 Apr 3;144(3614):45–52.  
13.  Hecht S. Rods, Cones, and the Chemical Basis of Vision. Physiol Rev. 1937 Apr 
1;17(2):239–90.  
14.  Crescitelli F. Physiology of Vision. Annu Rev Physiol. 1960 Mar 1;22(1):525–78.  
15.  Arshavsky VY, Lamb TD, Pugh EN. G Proteins and Phototransduction. Annu Rev Physiol. 
2002 Mar 1;64(1):153–87.  
16.  Winslow RL, Knapp AG. Dynamic models of the retinal horizontal cell network. Prog 
Biophys Mol Biol. 1991 Jan 1;56(2):107–33.  
17.  Blatt GJ, Andersen RA, Stoner GR. Visual receptive field organization and cortico-
cortical connections of the lateral intraparietal area (area LIP) in the macaque. J Comp Neurol. 
1990 Sep 22;299(4):421–45.  
18.  Kupfer C, Chumbley L, Downer JC. Quantitative histology of optic nerve, optic tract and 
lateral geniculate nucleus of man. J Anat. 1967 Jun;101(Pt 3):393–401.  
107 
 
19.  Tootell RB, Hadjikhani NK, Vanduffel W, Liu AK, Mendola JD, Sereno MI, et al. 
Functional analysis of primary visual cortex (V1) in humans. Proc Natl Acad Sci U S A. 1998 Feb 
3;95(3):811–7.  
20.  Gilbert CD, Wiesel TN. Receptive field dynamics in adult primary visual cortex. Nature. 
1992 Mar 12;356(6365):150–2.  
21.  Horton JC, Hoyt WF. Quadrantic visual field defects. A hallmark of lesions in 
extrastriate (V2/V3) cortex. Brain J Neurol. 1991 Aug;114 ( Pt 4):1703–18.  
22.  Engel SA, Rumelhart DE, Wandell BA, Lee AT, Glover GH, Chichilnisky E-J, et al. fMRI of 
human visual cortex. Nature. 1994 Jun 16;369(6481):525–525.  
23.  Hubel DH, Wiesel TN. Laminar and columnar distribution of geniculo-cortical fibers in 
the macaque monkey. J Comp Neurol. 1972 Dec;146(4):421–50.  
24.  Adams DL, Sincich LC, Horton JC. Complete Pattern of Ocular Dominance Columns in 
Human Primary Visual Cortex. J Neurosci. 2007 Sep 26;27(39):10391–403.  
25.  Porter JD, Baker RS, Ragusa RJ, Brueckner JK. Extraocular muscles: basic and clinical 
aspects of structure and function. Surv Ophthalmol. 1995 Jun;39(6):451–84.  
26.  Schor CM, Tyler CW. Spatio-temporal properties of Panum’s fusional area. Vision Res. 
1981;21(5):683–92.  
27.  Fredenburg P, Harwerth RS. The relative sensitivities of sensory and motor fusion to 
small binocular disparities. Vision Res. 2001 Jul;41(15):1969–79.  
28.  Garding J, Porrill J, Mayhew JEW, Frisby JP. Stereopsis, vertical disparity and relief 
transformations. Vision Res. 1995 Mar;35(5):703–22.  
29.  Olitsky SE, Nelson BA, Brooks S. The sensitive period of visual development in humans. 
J Pediatr Ophthalmol Strabismus. 2002 Apr;39(2):69-72; quiz 105-6.  
30.  Tuntivanich N, Petersen-Jones SM, Steibel JP, Johnson C, Forcier JQ. Postnatal 
development of canine axial globe length measured by B-scan ultrasonography. Vet 
Ophthalmol. 2007 Jan;10(1):2–5.  
31.  Perry VH, Henderson Z, Linden R. Postnatal changes in retinal ganglion cell and optic 
axon populations in the pigmented rat. J Comp Neurol. 1983 Sep 20;219(3):356–68.  
32.  Wiesel TN. Postnatal development of the visual cortex and the influence of 
environment. Nature. 1982 Oct 14;299(5884):583–91.  
33.  Hubel DH, Wiesel TN. The period of susceptibility to the physiological effects of 
unilateral eye closure in kittens. J Physiol. 1970 Feb;206(2):419–36.  
34.  Adams GGW, Sloper JJ. Update on squint and amblyopia. J R Soc Med. 2003 
Jan;96(1):3–6.  
35.  Lai Y-H, Wang H-Z, Hsu H-T. Development of visual acuity in preschool children as 
measured with Landolt C and Tumbling E charts. J Am Assoc Pediatr Ophthalmol Strabismus 
JAAPOS. 2011 Jun 1;15(3):251–5.  
108 
 
36.  Hubel DH, Wiesel TN. Receptive fields, binocular interaction and functional 
architecture in the cat’s visual cortex. J Physiol. 1962 Jan 1;160(1):106–54.  
37.  Knudsen EI. Sensitive Periods in the Development of the Brain and Behavior. J Cogn 
Neurosci. 2004 Oct;16(8):1412–25.  
38.  Levi DM, Polat U. Neural plasticity in adults with amblyopia. Proc Natl Acad Sci. 1996 
Jun 25;93(13):6830–4.  
39.  Attebo K, Mitchell P, Smith W. Visual Acuity and the Causes of Visual Loss in Australia. 
Ophthalmology. 1996 Mar 1;103(3):357–64.  
40.  Holmes JM, Clarke MP. Amblyopia. The Lancet. 2006 Apr 28;367(9519):1343–51.  
41.  Friendly DS. Amblyopia: definition, classification, diagnosis, and management 
considerations for pediatricians, family physicians, and general practitioners. Pediatr Clin North 
Am. 1987 Dec;34(6):1389–401.  
42.  The B4 School Check - A handbook for Practitioners - b4sc-practitionershandbook-
march2010.pdf [Internet]. [cited 2016 Oct 17]. Available from: 
http://www.moh.govt.nz/notebook/nbbooks.nsf/0/9de5d356a2c8f2cacc2577140005fad9/$FIL
E/b4sc-practitionershandbook-march2010.pdf 
43.  McKee SP, Levi DM, Movshon JA. The pattern of visual deficits in amblyopia. J Vis. 2003 
Jul 15;3(5):5.  
44.  Robaei D, Rose KA, Ojaimi E, Kifley A, Martin FJ, Mitchell P. Causes and associations of 
amblyopia in a population-based sample of 6-year-old Australian children. Arch Ophthalmol 
Chic Ill 1960. 2006 Jun;124(6):878–84.  
45.  Webber AL, Wood JM, Gole GA, Brown B. The Effect of Amblyopia on Fine Motor Skills 
in Children. Investig Opthalmology Vis Sci. 2008 Feb 1;49(2):594.  
46.  Shotton K, Elliott S. Interventions for strabismic amblyopia. Cochrane Database Syst 
Rev. 2008 Apr 16;(2):CD006461.  
47.  Holmes JM, Repka MX, Kraker RT, Clarke MP. The Treatment of Amblyopia. 
Strabismus. 2006 Jan 1;14(1):37–42.  
48.  Rahi JS, Logan S, Borja MC, Timms C, Russell-Eggitt I, Taylor D. Prediction of improved 
vision in the amblyopic eye after visual loss in the non-amblyopic eye. Lancet Lond Engl. 2002 
Aug 24;360(9333):621–2.  
49.  Epelbaum M, Milleret C, Buisseret P, Duffer JL. The Sensitive Period for Strabismic 
Amblyopia in Humans. Ophthalmology. 1993 Mar 1;100(3):323–7.  
50.  Eggers HM, Blakemore C. Physiological basis of anisometropic amblyopia. Science. 
1978 Jul 21;201(4352):264–7.  
51.  Barnes GR, Hess RF, Dumoulin SO, Achtman RL, Pike GB. The cortical deficit in humans 
with strabismic amblyopia. J Physiol. 2001 May 1;533(1):281–97.  
109 
 
52.  Wiesel TN, Hubel DH. Single-Cell Responses in Striate Cortex of Kittens Deprived of 
Vision in One Eye. J Neurophysiol. 1963 Nov 1;26(6):1003–17.  
53.  Siegwart JT, Norton TT. Perspective: How Might Emmetropization and Genetic Factors 
Produce                     Myopia in Normal Eyes? Optom Vis Sci Off Publ Am Acad Optom. 2011 
Mar;88(3):E365–72.  
54.  Troilo D, Wallman J. The regulation of eye growth and refractive state: An 
experimental study of emmetropization. Vision Res. 1991;31(7–8):1237–50.  
55.  Borchert MS, Varma R, Cotter SA, Tarczy-Hornoch K, McKean-Cowdin R, Lin JH, et al. 
Risk Factors for Hyperopia and Myopia in Preschool Children: The Multi-Ethnic Pediatric Eye 
Disease and Baltimore Pediatric Eye Disease Studies. Ophthalmology. 2011 Oct;118(10):1966–
73.  
56.  Prakash P. Amblyopia in myopia. Indian J Ophthalmol. 1983 Dec 1;31(7):807.  
57.  Clinical Guidelines for the Children’s Spectacle Subsidy [Internet]. 
www.disabilityfunding.co.nz. 2014 [cited 2016 Nov 25]. Available from: 
https://www.disabilityfunding.co.nz/__data/assets/pdf_file/0004/94027/CSS-clinical-
Guidelines-final-Oct-14.pdf 
58.  Group M-EPEDS. Prevalence of Myopia and Hyperopia in 6- to 72-Month-Old African 
American and Hispanic Children: The Multi-Ethnic Pediatric Eye Disease Study. Ophthalmology. 
2010 Jan;117(1):140–147.e3.  
59.  Matsumura H, Hirai H. Prevalence of Myopia and Refractive Changes in Students From 
3 to 17 Years of Age. Surv Ophthalmol. 1999 Oct;44, Supplement 1:S109–15.  
60.  Lin LLK, Shih Y-F, Hsiao CK, Chen CJ. Prevalence of Myopia in Taiwanese 
Schoolchildren: 1983 to 2000. Ann Acad Med Singapore. 2004;33(1):27–33.  
61.  Pan C-W, Ramamurthy D, Saw S-M. Worldwide prevalence and risk factors for myopia. 
Ophthalmic Physiol Opt. 2012 Jan;32(1):3–16.  
62.  Hornbeak DM, Young TL. Myopia genetics: a review of current research and emerging 
trends: Curr Opin Ophthalmol. 2009 Sep;20(5):356–62.  
63.  Morgan I, Rose K. How genetic is school myopia? Prog Retin Eye Res. 2005 Jan;24(1):1–
38.  
64.  Wojciechowski R. Nature and nurture: the complex genetics of myopia and refractive 
error. Clin Genet. 2011 Apr 1;79(4):301–20.  
65.  Parssinen O, Lyyra A-L. Myopia and myopic progression among schoolchildren: A 
three-year follow- up study. Invest Ophthalmol Vis Sci. 1993;34(9):2794–802.  
66.  Ip JM, Robaei D, Kifley A, Wang JJ, Rose KA, Mitchell P. Prevalence of Hyperopia and 
Associations with Eye Findings in 6- and 12-Year-Olds. Ophthalmology. 2008 Apr;115(4):678–
685.e1.  
67.  Ingram RM, Traynar MJ, Walker C, Wilson JM. Screening for refractive errors at age 1 
year: a pilot study. Br J Ophthalmol. 1979 Apr 1;63(4):243–50.  
110 
 
68.  Wen G, Tarczy-Hornoch K, McKean-Cowdin R, Cotter SA, Borchert M, Lin J, et al. 
Prevalence of Myopia, Hyperopia, and Astigmatism in Non-Hispanic White and Asian Children: 
Multi-Ethnic Pediatric Eye Disease Study. Ophthalmology. 2013 Oct;120(10):2109–16.  
69.  Fan DSP, Rao SK, Cheung EYY, Islam M, Chew S, Lam DSC. Astigmatism in Chinese 
preschool children: prevalence, change, and effect on refractive development. Br J 
Ophthalmol. 2004 Jul 1;88(7):938–41.  
70.  Abrahamsson M, Sjöstrand J. Astigmatic axis and amblyopia in childhood. Acta 
Ophthalmol Scand. 2003 Feb 1;81(1):33–7.  
71.  Barrett BT, Bradley A, Candy TR. The Relationship between Anisometropia and 
Amblyopia. Prog Retin Eye Res. 2013 Sep;36:120–58.  
72.  Kutschke PJ, Scott WE, Keech RV. Anisometropic amblyopia. Ophthalmology. 1991 
Feb;98(2):258–63.  
73.  Woodruff G, Hiscox F, Thompson JR, Smith LK. The presentation of children with 
amblyopia. Eye. 1994 Nov;8(6):623–6.  
74.  Leon A, Donahue SP, Morrison DG, Estes RL, Li C. The age-dependent effect of 
anisometropia magnitude on anisometropic amblyopia severity. J Am Assoc Pediatr 
Ophthalmol Strabismus. 2008 Apr;12(2):150–6.  
75.  Czepita D, Gosławski W, Mojsa A. [Occurrence of anisometropia among students 
ranging from 6 to 18 years of age]. Klin Oczna. 2005;107(4–6):297–9.  
76.  Huynh SC, Wang XY, Ip J, Robaei D, Kifley A, Rose KA, et al. Prevalence and associations 
of anisometropia and aniso-astigmatism in a population based sample of 6 year old children. 
Br J Ophthalmol. 2006 May 1;90(5):597–601.  
77.  de Vries J. Anisometropia in children: analysis of a hospital population. Br J 
Ophthalmol. 1985 Jul;69(7):504–7.  
78.  Pediatric Eye Disease Investigator Group. The clinical profile of moderate amblyopia in 
children younger than 7 years. Arch Ophthalmol Chic Ill 1960. 2002 Mar;120(3):281–7.  
79.  McCarthy P. Anisometropia: what difference does it make? Optom Pract 2 [Internet]. 
[cited 2016 Nov 25]; Available from: http://www.college-
optometrists.org/filemanager/root/site_assets/oip/14-1/6178_oip_vol_14_issue_1-
2013_1_p1-10_mccarthy_interactive_d5_5.pdf 
80.  Group MPEDS. Prevalence of Amblyopia and Strabismus in African American and 
Hispanic Children Ages 6 to 72 Months: The Multi-ethnic Pediatric Eye Disease Study. 
Ophthalmology. 2008 Jul;115(7):1229–1236.e1.  
81.  Graham PA. Epidemiology of strabismus. Br J Ophthalmol. 1974 Mar 1;58(3):224–31.  
82.  Holmström G, Rydberg A, Larsson E. Prevalence and Development of Strabismus in 10-
Year-Old Premature Children: A Population-Based Study. J Pediatr Ophthalmol Strabismus. 
2006 Dec;43(6):346–52.  
111 
 
83.  Chew E, Remaley NA, Tamboli A, Zhao J, Podgor MJ, Klebanoff M. Risk Factors for 
Esotropia and Exotropia. Arch Ophthalmol. 1994 Oct 1;112(10):1349–55.  
84.  Mohney BG. Common forms of childhood esotropia. Ophthalmology. 2001 
Apr;108(4):805–9.  
85.  Kothari M, Mody K, Walinjkar J, Madia J, Kaul S. Paralysis of the near-vision triad in a 
child. J Am Assoc Pediatr Ophthalmol Strabismus. 2009 Apr;13(2):202–3.  
86.  Greenberg AE, Mohney BG, Diehl NN, Burke JP. Incidence and Types of Childhood 
Esotropia: A Population-Based Study. Ophthalmology. 2007 Jan;114(1):170–4.  
87.  Costenbader F, Bair D, McPHAIL A. VISION IN STRABISMUS: A Preliminary Report. Arch 
Ophthalmol. 1948 Oct 1;40(4):438–53.  
88.  Archer SM, Musch DC, Wren PA, Guire KE, Del Monte MA. Social and Emotional Impact 
of Strabismus Surgery on Quality of Life in Children. J Am Assoc Pediatr Ophthalmol 
Strabismus. 2005 Apr;9(2):148–51.  
89.  Satterfield D, Keltner JL, Morrison TL. Psychosocial Aspects of Strabismus Study. Arch 
Ophthalmol. 1993 Aug 1;111(8):1100–5.  
90.  Jackson S, Harrad RA, Morris M, Rumsey N. The psychosocial benefits of corrective 
surgery for adults with strabismus. Br J Ophthalmol. 2006 Jul;90(7):883–8.  
91.  Prevalence of Amblyopia and Strabismus in African American and Hispanic Children 
Ages 6 to 72 Months. Ophthalmology. 2008 Jul 1;115(7):1229–1236.e1.  
92.  Neumann E, Friedman Z, Abel-Peleg B. Prevention of strabismic amblyopia of early 
onset with special reference to the optimal age for screening. J Pediatr Ophthalmol 
Strabismus. 1987 Jun;24(3):106–10.  
93.  Awaya S, Miyake S. Form vision deprivation amblyopia: Further observations. Graefes 
Arch Clin Exp Ophthalmol. 1988 Mar;226(2):132–6.  
94.  Shaw DE, Minshull C, Fielder AR, Rosenthal AR. Originally published as Volume 2, Issue 
8604AMBLYOPIA—FACTORS INFLUENCING AGE OF PRESENTATION. The Lancet. 1988 Jul 
23;332(8604):207–9.  
95.  Thompson JR, Woodruff G, Hiscox FA, Strong N, Minshull C. The incidence and 
prevalence of amblyopia detected in childhood. Public Health. 1991 Nov 1;105(6):455–62.  
96.  Simpson A, Kirkland C, Silva PA. Vision and eye problems in seven year olds: a report 
from the Dunedin Multidisciplinary Health and Development Research Unit. N Z Med J. 1984 
Jul 11;97(759):445–9.  
97.  Friedman DS, Repka MX, Katz J, Giordano L, Ibironke J, Hawse P, et al. Prevalence of 
Amblyopia and Strabismus in White and African American Children Aged 6 through 71 Months: 
The Baltimore Pediatric Eye Disease Study. Ophthalmology. 2009 Nov;116(11):2128–2134.e2.  
98.  Wilson GA, Welch D. Does amblyopia have a functional impact? Findings from the 




99.  O’Colmain U, Low L, Gilmour C, MacEwen CJ. Vision screening in children: a 
retrospective study of social and demographic factors with regards to visual outcomes. Br J 
Ophthalmol. 2015 Nov 23;  
100.  Simons K. Amblyopia Characterization, Treatment, and Prophylaxis. Surv Ophthalmol. 
2005 Mar 1;50(2):123–66.  
101.  Öner V, Bulut A, Büyüktarakçı Ş, Kaim M. Influence of hyperopia and amblyopia on 
choroidal thickness in children. Eur J Ophthalmol. 2015 Oct 31;0.  
102.  Hubel DH, Wiesel TN. Binocular Interaction in Striate Cortex of Kittens Reared with 
Artificial Squint. J Neurophysiol. 1965 Nov 1;28(6):1041–59.  
103.  Clavagnier S, Dumoulin SO, Hess RF. Is the Cortical Deficit in Amblyopia Due to 
Reduced Cortical Magnification, Loss of Neural Resolution, or Neural Disorganization? J 
Neurosci Off J Soc Neurosci. 2015 Nov 4;35(44):14740–55.  
104.  Levi DM. Visual Processing in Amblyopia: Human Studies. Strabismus 09273972. 2006 
Mar;14(1):11–9.  
105.  Woodruff G, Hiscox F, Thompson JR, Smith LK. Factors affecting the outcome of 
children treated for amblyopia. Eye. 1994 Nov;8(6):627–31.  
106.  Stewart CE, Fielder AR, Stephens DA, Moseley MJ. Treatment of unilateral amblyopia: 
factors influencing visual outcome. Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3152–60.  
107.  Stuart JA, Burian HM. A Study of Separation Difficulty*. Am J Ophthalmol. 1962 Mar 
1;53(3):471–7.  
108.  Webber AL. Amblyopia treatment: an evidence-based approach to maximising 
treatment outcome. Clin Exp Optom. 2007 Jul 1;90(4):250–7.  
109.  Hess RF, Howell ER. The threshold contrast sensitivity function in strabismic 
amblyopia: Evidence for a two type classification. Vision Res. 1977;17(9):1049–55.  
110.  Schmidt P, Maguire M, Dobson V, Quinn G, Ciner E, Cyert L, et al. Comparison of 
preschool vision screening tests as administered by licensed eye care professionals in the 
Vision In Preschoolers Study. Ophthalmology. 2004 Apr;111(4):637–50.  
111.  Held R, Birch E, Gwiazda J. Stereoacuity of human infants. Proc Natl Acad Sci. 1980 Sep 
1;77(9):5572–4.  
112.  Chatzistefanou KI, Theodossiadis GP, Damanakis AG, Ladas ID, Moschos MN, 
Chimonidou E. Contrast Sensitivity in Amblyopia: The Fellow Eye of Untreated and Successfully 
Treated Amblyopes. J Am Assoc Pediatr Ophthalmol Strabismus. 2005 Oct;9(5):468–74.  
113.  Lennerstrand G, Jakobsson P, Kvarnström G. Screening for ocular dysfunction in 
children: approaching a common program. Acta Ophthalmol Scand Suppl. 1995;(214):26-38; 
discussion 39-40.  
114.  A prospective, pilot study of treatment of amblyopia in children 10 to <18 years old. 
Am J Ophthalmol. 2004 Mar 1;137(3):581–3.  
113 
 
115.  Cleary M. Efficacy of occlusion for strabismic amblyopia: can an optimal duration be 
identified? Br J Ophthalmol. 2000 Jun 1;84(6):572–8.  
116.  Repka MX, Cotter SA, Beck RW, Kraker RT, Birch EE, Everett DF, et al. A randomized 
trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology. 
2004 Nov;111(11):2076–85.  
117.  Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching 
for treatment of moderate amblyopia in children. Arch Ophthalmol Chic Ill 1960. 2002 
Mar;120(3):268–78.  
118.  Foley-Nolan A, McCann A, O’Keefe M. Atropine penalisation versus occlusion as the 
primary treatment for amblyopia. Br J Ophthalmol. 1997 Jan 1;81(1):54–7.  
119.  Bradford GM, Kutschke PJ, Scott WE. Results of Amblyopla Therapy in Eyes with 
Unilateral Structural Abnormalities. Ophthalmology. 1992 Oct 1;99(10):1616–21.  
120.  Kane J, Biernacki R, Fraine L, Fukuda N, Haskins K, Morrison DG. Patching Compliance 
with Full-Time vs. Part-Time Occlusion Therapy. Am Orthopt J. 2013 Jan 1;63(1):19–23.  
121.  Fulton AB, Mayer DL. Esotropic children with amblyopia: Effects of patching on acuity. 
Graefes Arch Clin Exp Ophthalmol. 1988 Jul;226(4):309–12.  
122.  Hiscox F, Strong N, Thompson JR, Minshull C, Woodruff G. Occlusion for amblyopia: A 
comprehensive survey of outcome. Eye. 1992 May;6(3):300–4.  
123.  Groenewoud JH, Tjiam AM, Lantau VK, Hoogeveen WC, de Faber JTHN, Juttmann RE, et 
al. Rotterdam AMblyopia Screening Effectiveness Study: Detection and Causes of Amblyopia in 
a Large Birth Cohort. Investig Opthalmology Vis Sci. 2010 Jul 1;51(7):3476.  
124.  Clarke MP, Wright CM, Hrisos S, Anderson JD, Henderson J, Richardson SR. 
Randomised controlled trial of treatment of unilateral visual impairment detected at preschool 
vision screening. BMJ. 2003 Nov 27;327(7426):1251.  
125.  Holmes JM, Kraker RT, Beck RW, Birch EE, Cotter SA, Everett DF, et al. A randomized 
trial of prescribed patching regimens for treatment of severe amblyopia in children. 
Ophthalmology. 2003 Nov;110(11):2075–87.  
126.  Hrisos S, Clarke MP, Wright CM. The emotional impact of amblyopia treatment in 
preschool children: randomized controlled trial. Ophthalmology. 2004 Aug;111(8):1550–6.  
127.  Simons K, Preslan M. Natural history of amblyopia untreated owing to lack of 
compliance. Br J Ophthalmol. 1999 May;83(5):582–7.  
128.  Rahi JS, Cumberland PM, Peckham CS. Does amblyopia affect educational, health, and 
social outcomes? Findings from 1958 British birth cohort. BMJ. 2006 Apr 6;332(7545):820–5.  
129.  Simons K. Old age and the functional consequences of amblyopia. J Am Assoc Pediatr 
Ophthalmol Strabismus. 2008 Oct;12(5):429–30.  
130.  Engel-Yeger B. Evaluation of gross motor abilities and self perception in children with 
amblyopia. Disabil Rehabil. 2008;30(4):243–8.  
114 
 
131.  Packwood EA, Cruz OA, Rychwalski PJ, Keech RV. The psychosocial effects of amblyopia 
study. J Am Assoc Pediatr Ophthalmol Strabismus. 1999 Feb;3(1):15–7.  
132.  Tommila V, Tarkkanen A. Incidence of loss of vision in the healthy eye in amblyopia. Br 
J Ophthalmol. 1981 Aug 1;65(8):575–7.  
133.  Hoyt CS. Why is the adult amblyopic eye unstable? Br J Ophthalmol. 2004 Sep 
1;88(9):1105–6.  
134.  WILSON JMG, JUNGNER G. Principles and practice of screening for disease. 
1968;(34):163 pp.  
135.  Sheehy AM, Coursin DB, Gabbay RA. Back to Wilson and Jungner: 10 Good Reasons to 
Screen for Type 2 Diabetes Mellitus. Mayo Clin Proc. 2009 Jan;84(1):38–42.  
136.  Coppens JE, van den Berg TJTP. A new source of variance in visual acuity. Vision Res. 
2004 Apr;44(9):951–8.  
137.  Kaiser PK. Prospective Evaluation of Visual Acuity Assessment: A Comparison of Snellen 
Versus ETDRS Charts in Clinical Practice (An AOS Thesis). Trans Am Ophthalmol Soc. 2009 
Dec;107:311–24.  
138.  Kemper AR, Clark SJ. Preschool Vision Screening in Pediatric Practices. Clin Pediatr 
(Phila). 2006 Apr 1;45(3):263–6.  
139.  Marsh-Tootle WL, Frazier MG, Kohler CL, Dillard CM, Davis K, Schoenberger Y-M, et al. 
Exploring pre-school vision screening in primary care offices in Alabama. Optom Vis Sci Off 
Publ Am Acad Optom. 2012 Oct;89(10):1521–31.  
140.  Simons K. Preschool vision screening: Rationale, methodology and outcome. Surv 
Ophthalmol. 1996 Jul;41(1):3–30.  
141.  Webber AL, Wood J. Amblyopia: prevalence, natural history, functional effects and 
treatment. Clin Exp Optom. 2005 Nov;88(6):365–75.  
142.  Carlton J, Karnon J, Czoski-Murray C, Smith KJ, Marr J. The clinical effectiveness and 
cost-effectiveness of screening programmes for amblyopia and strabismus in children up to 
the age of 4–5 years: a systematic review and economic evaluation [Internet]. NIHR Journals 
Library; 2008 [cited 2016 May 30]. Available from: 
http://www.ncbi.nlm.nih.gov/books/NBK56835/ 
143.  Schlichtherle S, Gandjour A, Neugebauer A, Rüssmann W, Lauterbach KW. The cost-
effectiveness of screening strategies for amblyopia: a preliminary report. Strabismus. 2000 
Dec;8(4):291–5.  
144.  Rein DB, Wittenborn JS, Zhang X, Song M, Saaddine JB, Vision Cost-effectiveness Study 
Group. The potential cost-effectiveness of amblyopia screening programs. J Pediatr 
Ophthalmol Strabismus. 2012 Jun;49(3):146-155; quiz 145, 156.  
145.  Friedman DS, Cassard SD, Williams SK, Baldonado K, O’Brien RW, Gower EW. 
Outcomes of a vision screening program for underserved populations in the United States. 
Ophthalmic Epidemiol. 2013 Aug;20(4):201–11.  
115 
 
146.  Bray LC, Clarke MP, Jarvis SN, Francis PM, Colver A. Preschool vision screening: A 
prospective comparative evaluation. Eye. 1996 Nov;10(6):714–8.  
147.  Jarvis SN, Tamhne RC, Thompson L, Francis PM, Anderson J, Colver AF. Preschool vision 
screening. Arch Dis Child. 1991 Mar 1;66(3):288–94.  
148.  Stewart-Brown SL, Haslum MN, Howlett B. Preschool vision screening: a service in 
need of rationalisation. Arch Dis Child. 1988 Apr;63(4):356–9.  
149.  Williams C, Northstone K, Harrad RA, Sparrow JM, Harvey I. Amblyopia treatment 
outcomes after screening before or at age 3 years: follow up from randomised trial. BMJ. 2002 
Jun 29;324(7353):1549.  
150.  Chou R, Dana T, Bougatsos C. Screening for Visual Impairment in Children Ages 1-5 
Years: Systematic Review to Update the 2004 U.S. Preventive Services Task Force 
Recommendation [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 
2011 [cited 2016 Jan 3]. (U.S. Preventive Services Task Force Evidence Syntheses, formerly 
Systematic Evidence Reviews). Available from: 
http://www.ncbi.nlm.nih.gov/books/NBK52708/ 
151.  Dahlmann-Noor AH, Vrotsou K, Kostakis V, Brown J, Heath J, Iron A, et al. Vision 
screening in children by Plusoptix Vision Screener compared with gold-standard orthoptic 
assessment. Br J Ophthalmol. 2009 Mar 1;93(3):342–5.  
152.  Matta NS, Singman EL, Silbert DI. Performance of the Plusoptix vision screener for the 
detection of amblyopia risk factors in children. J Am Assoc Pediatr Ophthalmol Strabismus 
JAAPOS. 2008 Oct 1;12(5):490–2.  
153.  Arnold RW, Tulip D, McArthur E, Shen J, Tappel J, Arnold LE, et al. Predictive value from 
pediatrician plusoptix screening: impact of refraction and binocular alignment. Binocul Vis 
Strabol Q Simms-Romanos. 2012;27(4):227–32.  
154.  Hoyt CS. Objective techniques of visual acuity assessment in infancy. Aust N Z J 
Ophthalmol. 1986 Aug;14(3):205–9.  
155.  Committee on Practice and Ambulatory Medicine, Section on Ophthalmology. 
American Association of Certified Orthoptists, American Association for Pediatric 
Ophthalmology and Strabismus, American Academy of Ophthalmology. Eye examination in 
infants, children, and young adults by pediatricians. Pediatrics. 2003 Apr;111(4 Pt 1):902–7.  
156.  Neugebauer A, Reier M, Fricke J, Rüssmann W. [Childhood vision disorders. Screening 
programs in international comparison]. Ophthalmol Z Dtsch Ophthalmol Ges. 2002 
Jan;99(1):32–7.  
157.  Tests and models for screening to prevent blindness in infants and children: a rapid 
review update of the evidence - tests-and-models-for-screening-to-prevent-blindness.pdf 





158.  NATIONAL CHILDREN’S - Vision_Screening_Final_Report_May_2009.pdf [Internet]. 
[cited 2017 Apr 2]. Available from: 
http://www.rch.org.au/uploadedFiles/Main/Content/ccch/Vision_Screening_Final_Report_Ma
y_2009.pdf 
159.  Vision Defects [Internet]. [cited 2017 Apr 2]. Available from: 
https://legacyscreening.phe.org.uk/vision-child 
160.  Hendler K, Mehravaran S, Lu X, Brown SI, Mondino BJ, Coleman AL. Refractive Errors 
and Amblyopia in the UCLA Preschool Vision Program; First Year Results. Am J Ophthalmol. 
2016 Dec;172:80–6.  
161.  Matsuo T, Matsuo C, Matsuoka H, Kio K. Detection of strabismus and amblyopia in 1.5- 
and 3-year-old children by a preschool vision-screening program in Japan. Acta Med Okayama. 
2007 Feb;61(1):9–16.  
162.  Kvarnström G, Jakobsson P, Lennerstrand G. Visual screening of Swedish children: an 
ophthalmological evaluation. Acta Ophthalmol Scand. 2001 Jun;79(3):240–4.  
163.  Hopkins S, Sampson GP, Hendicott P, Wood JM. Review of guidelines for children’s 
vision screenings. Clin Exp Optom. 2013 Sep 1;96(5):443–9.  
164.  Toufeeq A, Oram AJ. School-entry Vision Screening in the United Kingdom: Practical 
Aspects and Outcomes. Ophthalmic Epidemiol. 2014 Aug;21(4):210–6.  
165.  Barry J-C, König H-H. Test characteristics of orthoptic screening examination in 3 year 
old kindergarten children. Br J Ophthalmol. 2003 Jul 1;87(7):909–16.  
166.  Nawratzki I, Oliver M, Newmann E. Screening for amblyopia. Screening for amblyopia 
in children under three years of age in Israel. Isr J Med Sci. 1972 Sep;8(8):1469–72.  
167.  Tjiam AM, Groenewoud JH, Passchier J, Loudon SE, De Graaf M, Hoogeveen WC, et al. 
Determinants and outcome of unsuccessful referral after positive screening in a large birth-
cohort study of population-based vision screening. J AAPOS Off Publ Am Assoc Pediatr 
Ophthalmol Strabismus. 2011 Jun;15(3):256–62.  
168.  Langeslag-Smith MA, Vandal AC, Briane V, Thompson B, Anstice NS. Preschool 
children’s vision screening in New Zealand: a retrospective evaluation of referral accuracy. BMJ 
Open. 2015 Nov 1;5(11):e009207.  
169.  Hård A-L. Results of vision screening of 6-year-olds at school: a population-based study 
with emphasis on screening limits. Acta Ophthalmol Scand. 2007 Jun;85(4):415–8.  
170.  Khandekar R, Parast N, Arabi A. Evaluation of ‘vision screening’ program for three to 
six-year-old children in the Republic of Iran. Indian J Ophthalmol. 2009;57(6):437–42.  
171.  Mema SC, McIntyre L, Musto R. Childhood vision screening in Canada: public health 
evidence and practice. Can J Public Health Rev Can Sante Publique. 2012 Feb;103(1):40–5.  
172.  Juttmann R, Rotterdam AMblyopia Screening Effectiveness Study (RAMSES) steering 
committee. The Rotterdam AMblyopia Screening Effectiveness Study (RAMSES): compliance 
and predictive value in the first 2 years. Br J Ophthalmol. 2001 Nov;85(11):1332–5.  
117 
 
173.  Peterseim MMW, Papa CE, Wilson ME, Davidson JD, Shtessel M, Husain M, et al. The 
effectiveness of the Spot Vision Screener in detecting amblyopia risk factors. J AAPOS Off Publ 
Am Assoc Pediatr Ophthalmol Strabismus Am Assoc Pediatr Ophthalmol Strabismus. 2014 
Dec;18(6):539–42.  
174.  Chang C-H, Tsai R-K, Sheu M-M. Screening amblyopia of preschool children with 
uncorrected vision and stereopsis tests in Eastern Taiwan. Eye. 2006 Sep 1;21(12):1482–8.  
175.  Rivakani F, Torabi L, Rafiei M, Arabi A, Alaeddini F, Abbasi-Ghahramanloo A, et al. The 
Sensitivity, Specificity and Predictive Values of Snellen Chart Compared to the Diagnostic Test 
in Amblyopia Screening Program in Iran. Int J Pediatr. 2015 Dec 1;3(6.2):1125–33.  
176.  Tong PY, Bassin RE, Enke-Miyazaki E, Macke JP, Tielsch JM, Stager DR, et al. Screening 
for amblyopia in preverbal children with photoscreening photographs: II. Sensitivity and 
specificity of the MTI photoscreener. Ophthalmology. 2000 Sep;107(9):1623–9.  
177.  Ying G-S, Kulp MT, Maguire M, Ciner E, Cyert L, Schmidt P, et al. Sensitivity of screening 
tests for detecting vision in preschoolers-targeted vision disorders when specificity is 94%. 
Optom Vis Sci Off Publ Am Acad Optom. 2005 May;82(5):432–8.  
178.  Eibschitz-Tsimhoni M, Friedman T, Naor J, Eibschitz N, Friedman Z. Early screening for 
amblyogenic risk factors lowers the prevalence and severity of amblyopia. J Am Assoc Pediatr 
Ophthalmol Strabismus. 2000 Aug;4(4):194–9.  
179.  Liang SL-H, Fricke TR. Diagnosis and management of accommodative esotropia. Clin 
Exp Optom. 2006 Sep 1;89(5):325–31.  
180.  Grosvenor T. Refractive Error Distribution In New Zealand’s Polynesian And European 










































Optometry Data Sheet for VHT Study 
1 April to 31 October 2016 
 
Date Seen: _____________________ 
Demographic Details: 




   
____________________________________________________________________ 
 
Source of Referral: 
 VHT ☐   GP ☐   Parent ☐  Teacher ☐ 
 
 
Unaided Visual Acuity:           Best Corrected Visual Acuity: 
Right eye: __________Left eye: __________     Right eye: __________Left eye: 
___________  
Test Used:  
Snellen Chart ☐ Parr Letter Matching ☐ Lea Symbols ☐  Other ☐
  
 
Presence of Amblyopia:           yes/no        (please circle one) 
(Note: For this study, amblyopia is defined as a VA of 6/12 in either eye, or a two line 
difference or greater between eyes) 





Cycloplegic Refraction ___________________________________________________ 




Glasses ☐ Patching ☐  Ophthalmology Referral ☐  Discharge ☐ 
 
